HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
February 23, 2021TRAUMATIC BRAIN INJURY (HEALING)
February 23, 2021- A case of advanced cervical esophageal cancer with liver cirrhosis and diabetes mellitus showing a complete response by radiation therapy after the operation for …
- A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus
- A case of central diabetes insipidus caused by metastatic small cell lung cancer
- A Case of Central diabetes Insipidus in Patient with Non-small Cell Lung cancer.
- A case of diabetes mellitus accompanied by tumor-forming pancreatitis that was difficult to distinguish from pancreatic cancer
- A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus-about the control of blood glucose when …
- A Case of Fulminant Type 1 diabetes Mellitus and Diabetic Ketoacidosis Caused by Adjuvant Chemotherapy for Colon cancer
- A case of lung cancer with pituitary metastases presented by diabetes insipidus
- A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer
- A Case of Pituitary Metastasis of Breast cancer Presenting as diabetes Insipidus and Panhypopituitarism.
- A case of small cell lung cancer associated with diabetes insipidus and Cushing’s syndrome
- A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins
- A Case of Ulcerative Colitis Combined with Follicular Thyroid cancer and Gestational diabetes Mellitus
- A case-control study of diabetes mellitus and cancer risk
- A Clinical Analysis of Endometrial cancer Accompanied by Hypertension and diabetes Mellitus
- A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes
- A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes.
- A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
- A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus
- A cohort study of the risk of cancer associated with type 2 diabetes
- A COMPARISON OF SPIRITUAL DEVELOPMENT BETWEEN HEALTHY INDIVIDUALS AND PATIENTS SUFFERING FROM cancer AND diabetes
- A Comprehensive Analysis of diabetes Self-Management among with Men with Prostate cancer in the United States: Evidence from the National Health and Nutrition …
- A Connecting Switch Among Aging, diabetes and Tumor: Avenue Leading to cancer Therapeutics
- A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
- A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan
- A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)—Potsdam Study cohort
- A genetic link between type 2 diabetes and prostate cancer
- A genetic relationship between diabetes and cancer
- A high diet quality based on dietary recommendations is not associated with lower incidence of type 2 diabetes in the Malmö Diet and cancer Cohort
- A high rate of undiagnosed diabetes in new uterine cancer patients
- A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
- A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breast cancer Outcome in Patients with diabetes Mellitus.
- A meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer
- A meta-analysis of diabetes mellitus and the risk of prostate cancer
- A molecular rheostat at the interface of cancer and diabetes
- A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
- A new approach for diagnosis of diabetes and prediction of cancer using ANFIS
- A new ınsight ınto metformin action: diabetes, prostate cancer, and ıon channels
- A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
- A New Role for an Old Drug: Metformin Targets Micro RNA s in Treating diabetes and cancer
- A noninvasive method to detect diabetes mellitus and lung cancer using the stacked sparse autoencoder
- A novel approach for the diagnosis of diabetes and liver cancer using ANFIS and improved KNN
- A NOVEL APPROACH IN COLORECTAL cancer AND diabetes MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN
- A novel design and analysis of high-sensitivity biosensor based on nano-cavity for detection of blood component, diabetes, cancer and glucose concentration
- A novel mechanistic pathway linking diabetes to colorectal cancer: Role of AMPK and mTOR
- A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
- A Novel Pathway Linking Oxidative Stress and Inflammation: Prevention of cancer, Sepsis, Asthma, diabetes and Uveitis by Aldose Reductase Inhibition.
- A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
- A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a brenner tumor
- A pilot study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients
- A population-based cohort study of all-cause and site-specific cancer incidence among patients with type 1 diabetes mellitus in Taiwan
- A Potential Screening Strategy of Pancreatic cancer in New Onset diabetes Patients Using Serum CA19-9 in Combination With Age and BMI: 7
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 diabetes and Prostate cancer
- A Progressive Stack Face-based Network for Detecting diabetes Mellitus and Breast cancer
- A prospective study of the associations between treated diabetes and cancer outcomes
- A Prospective Study of the Associations Between Treated diabetes Mellitus and cancer Outcomes
- A prospective study of type 2 diabetes, metformin use, and risk of breast cancer
- A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk
- A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer
- A retrospective study of the impact of diabetes mellitus on survival in patients with tung cancer
- A retrospective study on the role of diabetes and metformin in colorectal cancer disease progression.
- A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival
- A retrospective-analysis of the correlation between diabetes mellitus and cancer
- A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer
- A review of current knowledge: Role of diabetes, cancer and cytochrome P450
- A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes
- A Review of the Quality of Life of Hemodialysis, Breast cancer, and Type 2 diabetes Mellitus Patients
- A risk stratification schema for predicting diabetes mellitus in cancer survivors.
- A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study
- A Study of the People’s Medicine Scheme in Mumbai and Thane region, India with reference to cancer and diabetes medicines
- A study on implementation of national programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke in Udupi district, Karnataka
- A study on utilization of diagnostic and therapeutic services of National Program for Prevention and Control of cancer, diabetes and Cardiovascular Diseases …
- A SUCCESSFUL CASE OF GASTRIC cancer WITH diabetes MELLITUS IN 84 YEAR OLD MAN, TOTAL GASTRECTOMIZED WITH TRANSVERSE COLECTOMY
- A SURVEY ON IMPROVING THE PERFORMANCE OF cancer AND diabetes DETECTION BY USING NOVEL TECHNIQUE OF MACHINE LEARNING
- A Survey on The Roles of Life Style and Its Modification in The Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
- A systematic review of cases of diabetes mellitus following immune checkpoint inhibitor therapy for cancer
- A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
- A systematic review study on the communication between diabetes and cancer: The serious risk of cancer in diabetic patients
- A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
- A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?
- Aberrant Expression of Sialidase in cancer and diabetes
- Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer
- Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering …
- ABO blood group and diabetes mellitus influence the risk for pancreatic cancer in a population from China
- ABO blood type, diabetes and risk of gastrointestinal cancer in northern China
- ABO blood type, long-standing diabetes, and the risk of pancreatic cancer
- Abolish cancer progenitor cells in a mouse model of diabetes associated hepatocellular carcinoma
- Aboriginal and Torres Strait islander health: Accuracy of patient self‐report of screening for diabetes, high cholesterol and cervical cancer
- Abstract A08: Human preadipocytes promote pancreatic cancer cellular growth in a diabetes-specific manner
- Abstract A23: cancer outcomes in the diabetes prevention program outcomes study
- Abstract A23: Metformin as a potent antiangiogenic factor: From diabetes to cancer angioprevention
- Abstract A27: Association between diabetes pharmacotherapies and bladder cancer: A Medicare epidemiologic study
- Abstract A58: Interaction of diabetes and obesity in postmenopausal breast cancer risk among black women
- Abstract A76: diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
- Abstract B026: Occurrence of comorbidities among diverse hospice cancer patients with and without diabetes
- Abstract B17: Type 2 diabetes, metformin, and ovarian cancer survival: An analysis of tumor registry and electronic medical record data.
- Abstract B43: Type 2 diabetes mellitus and colorectal cancer risk in Hispanics: A pilot case-control study
- Abstract B45: Obesity, diabetes, other comorbidities and survival in a cohort of women with ovarian cancer
- Abstract B94: Relationship of overweight and diabetes with prostate cancer stages in Mexican Americans: A population-based case-control study
- Abstract C077: The association between diabetes, plasma fructosamine, and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white …
- Abstract C28: An exploratory study of co-occurrence of breast cancer and diabetes in medically underserved Latinas
- Abstract CT198: Efficacy of metfOrmin in PrevenTIng glucocorticoid-induced diabetes in Melanoma, breAst or Lung cancer patients with brain metastases: The phase …
- Abstract GS2-09: diabetes risk reduction diet and survival following breast cancer
- Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.
- Abstract LB-190: Ethnic differences in the relationship between diabetes, adiposity measures and breast cancer-specific mortality
- Abstract LB-278: Metformin exposure on survival in localized breast cancer patients with type II diabetes mellitus using electronic health records
- Abstract LB-285: Glycemia is positively associated with prostate cancer mortality in white and black men without diabetes when better classifying hyper-and …
- Abstract LB-296: Breast cancer metabolism in association with diabetes
- Abstract LB-421: diabetes pharmacotherapy: A potential modifier of breast cancer prognosis
- Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients
- Abstract P1-10-02: Type II diabetes and subtype-specific breast cancer risk in medically underserved black and white women
- Abstract P2-07-06: Obesity, dyslipidemia, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients
- Abstract P2-08-11: High prevalence and incidence of new onset diabetes in metastatic breast cancer
- Abstract P2-11-09: Weight Change and Risk of Incident diabetes After Breast cancer
- Abstract P3-02-10: The possible association among breast cancer, diabetes mellitus and GLP-1 receptor
- Abstract P3-10-32: Breast cancer Patients with Type 2 diabetes Trend To Be Associated with Poor Prognosis
- Abstract P344: Association of diabetes and cancer Mortality in American Indians: The Strong Heart Study
- Abstract P4-12-07: diabetes Increases the Risk of Breast cancer
- Abstract P4-13-08: diabetes, Related Factors and Breast cancer Risk
- Abstract P5-12-04: Association of adjuvant endocrine therapy with diabetes among women with postmenopausal breast cancer in the Women’s Health Initiative (WHI)
- Abstract P6-09-05: Insulin Resistance, diabetes Mellitus and Breast cancer Risk in Pre-and Postmenopausal Women: Modification Effect by Moderate Physical …
- Abstract P6-10-03: The association between type-2 diabetes and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women from …
- Abstract P6-10-12: Metformin increases survival in hormone receptor-positive, Her2-positive breast cancer patients with diabetes
- Abstract PD11-05: diabetes decreases overall survival in women with breast cancer in the southern community cohort study
- Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors
- Abstract PL05-02: Current therapies for diabetes-will they reduce cancer risk?
- Abstract PO-159: Mediation of black/white race disparity in triple-negative breast cancer: Effect of type 2 diabetes mellitus
- Abstract PO-215: diabetes and the quality of adjuvant therapy in Medicaid-insured women with breast cancer
- Abstract PO-237: Colorectal cancer screening in patients with type 2 diabetes mellitus
- Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus
- Abstract SY02-02: Shared risk factors for diabetes, cardiovascular disease, and cancer in a low-income population
- Abstract SY02-04: Risk factors associated with cancer, type 2 diabetes, and cardiovascular disease in the multiethnic cohort: Comparisons across ethnic groups
- Abstract# 2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
- Abstract# 2938: Treatment for diabetes mellitus-2 could prevent pancreatic cancer cell growth
- Acanthosis nigricans—decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin
- Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
- ACS/ADA/AHA issue core recommendations for preventing cancer, cardiovascular disease, and diabetes
- Activation of cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2 diabetes
- Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
- Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
- ADA, ACS Spotlight diabetes–cancer Links
- Adapted geometric semantic genetic programming for diabetes and breast cancer classification
- Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster
- Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
- Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes
- Addressing different biases in analysing drug use on cancer risk in diabetes in non‐clinical trial settings—what, why and how?
- Adenosine monophosphate–activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection
- Adherence to a healthy Nordic food index is associated with a lower risk of type-2 diabetes—The Danish diet, cancer and health cohort study
- Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010
- Adherence to Dietary Indexes by diabetes and Hypertension Status among PLCO cancer Screening Trial Participants
- Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment
- Adherence to the Danish food-based dietary guidelines and risk of type 2 diabetes: the Danish diet, cancer, and health cohort
- Adiponectin as a potential key player in metabolic syndrome: Insights into atherosclerosis, diabetes and cancer
- Adiposity and diabetes in breast and prostate cancer
- Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking
- Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women
- Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
- Adopting Nrf2 and NF-κB from cancer: Is there any role of the duo in diabetes?
- ADRB2 G–G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity
- Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood
- Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus
- Advanced glycation end products in diabetes, cancer and phytochemical therapy
- Advances in the studies of the link between diabetes and cancer
- Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes–focus on pancreatitis and pancreas cancer
- Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
- African American breast and endometrial cancer survivors with type 2 diabetes: Perceived barriers and preferred components for a physical activity program
- Age-related differences in the consequences of obesity on cardiovascular disease, type 2 diabetes, osteoarthritis, cancer, physical function, osteoporosis, cognitive …
- Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis
- AIDS, diabetes, and lung cancer mortality at the northern Mexican border: 1979-1997
- Akt enzyme: new therapeutic target in cancer and diabetes?
- Akt2 Redox-regulation in Breast cancer and diabetes
- Alarmins in chronic noncommunicable diseases: atherosclerosis, diabetes and cancer
- All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the …
- All‐cause cancer mortality over 15 years in multi‐ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance
- Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes and cancer
- Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8)
- Alternative splicing of insulin receptor mRNA in cancer and type 2 diabetes mellitus: a review
- American diabetes Association 60th Scientific Sessions, 2000: glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics
- AMP-activated protein kinase: a target for old drugs against diabetes and cancer
- AMPK activators as a drug for diabetes, cancer and cardiovascular disease
- AMPK-a nutrient and energy sensor with roles in diabetes, cancer and viral infection
- AMPK: a target for drugs and natural products with effects on both diabetes and cancer
- AMPK: therapeutic target for diabetes and cancer prevention
- An analysis of the impact of irrational beliefs and illness representation in predicting distress in cancer and type II diabetes patients
- An assessment of the shared allelic architecture between type II diabetes and prostate cancer
- An Australian man who stays he developed bladder cancer after using a diabetes drug is taking legal action against the drug’s manufacturer and distributor
- An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes
- An ecological association between the prevalence of diabetes Mellitus and the incidence of colorectal cancer
- An elevated HbA1c level is associated with short-term adverse outcomes in patients with gastrointestinal cancer and type 2 diabetes mellitus
- An epidemiology study of the relationship between pancreatic cancer and diabetes mellitus
- An experimental model of diabetes and cancer in rats
- An extended Myc network contributes to glucose homeostasis in cancer and diabetes
- An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
- An integrative hypothesis linking cancer, diabetes and atherosclerosis: the role of mutations and epigenetic changes
- An optimization approach to improve classification performance in cancer and diabetes prediction
- An uncommon case of T1b breast cancer with diabetic mastopathy in type II diabetes mellitus
- An Unusual Case of Emphysematous Cystitis in Non diabetes Metastatic Lung cancer Patient Undergoing Chemotherapy
- Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2 diabetes and cancer cachexia
- Analysis and prediction of breast cancer and diabetes disease datasets using data mining classification techniques
- Analysis of cardiovascular events or diabetes mellitus during androgen deprivation therapy in Korean prostate cancer patients
- Analysis of clinical data in breast cancer patients with type 2 diabetes
- Analysis of clinical features in colorectal cancer patients with Type 2 diabetes
- ANALYSIS OF CLINICAL FEATURES OF COLORECTAL cancer PATIENTS COMBINED TYPE 2 diabetes MELLITUS
- Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lung cancer Patients with diabetes Mellitus
- Analysis of functional genetic polymorphisms in prostate cancer and type 2 diabetes: Mucin 1 and growth hormone receptor
- Analysis of gene expression patterns and metabolomics correlated to obesity, diabetes, and outcomes in patients with epithelial ovarian cancer
- Analysis of microrna signatures as biomarker to investigate interlink between type 2 diabetes and breast cancer
- Analysis of perioperative treatment on 43 cases of gastric cancer complicated with diabetes mellitus [J]
- Analysis of Serum Growth Differentiation Factor-15 in Progression of Breast cancer in Type II diabetes Mellitus Patients
- Analysis of the association of diabetes mellitus with cancer using autopsy records
- Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors
- Analysis of the efficacy of surgical treatment for 80 elderly laryngeal cancer patients with type 2 diabetes
- Analysis on 57 cases of saving anus surgery for rectal cancer patients incorporated diabetes
- Analyzing Targeted Nucleosome Position and Occupancy in cancer, Obesity, and diabetes
- Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
- Androgen Deprivation Therapy in Patients with Advanced Prostate cancer and Type 2 diabetes Impairs Glucose and Lipid Metabolism: 64
- Androgen deprivation therapy increases the risk of diabetes and non-cancer mortality in prostate cancer patients: a meta-analysis
- Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer
- Androgen receptor overexpression in prostate cancer in type 2 diabetes
- Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer
- Androgens, diabetes and prostate cancer
- Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226
- Angiopoietin-like protein 2 is a useful biomarker for pancreatic cancer that is associated with type 2 diabetes mellitus and inflammation
- Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study
- Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists
- Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung diabetes Study
- Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
- Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- Anti-Diabetic Medications and Risk of Pancreatic cancer in Patients With diabetes Mellitus: A Systematic Review and Meta-Analysis
- Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
- Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
- Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrial cancer in women with type 2 diabetes
- Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
- Antidiabetic medications and mortality risk in individuals with pancreatic cancer–related diabetes and postpancreatitis diabetes: a nationwide cohort study
- Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- Antidiabetic medications use and cancer risk in type 2 diabetes
- Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer
- Application of microbiological and immunological enteral nutrition in patients with gastrointestinal cancer complicated with diabetes mellitus
- Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer
- Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
- Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes
- ARE diabetes MELLITUS AND CHROMOSOME 17Q12 GENETIC VARIANTS ASSOCIATED WITH PROSTATE cancer AGGRESSIVENESS?
- Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
- Are the Different diabetes Subgroups Correlated With All-Cause, cancer-Related, and Cardiovascular-Related Mortality?
- Are We doing a Better Job of Understanding Co-morbidity Conditions in Health Care (cancer, Tuberculosis, Hypertension, diabetes, etc.?
- Aspects épidémiologiques de l’association diabète et cancer: Epidemiological features of the diabetes–cancer association
- Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a ‘case study’
- Assessing the relationship between institutional cancer and diabetes mortality rates using National Death Index data
- Assessment of Blood Donation Safety by People Diagnosed with diabetes, Hypertension, Malaria and cancer
- Assessment of classification algorithms in the diagnosis of diabetes and breast cancer
- ASSESSMENT OF diabetes MELLITUS AS A MADHUMEHA AND cancer RISK–A REVIEW
- Assessment of implementation of the national programme for the prevention and control of cancer, diabetes, cardiovascular diseases, and stroke at …
- Assessment of quality of life in patients with cancer and diabetes 2 in Northern Greece
- Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
- Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort …
- Association Between Breast cancer and diabetes
- Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study
- Association between cancer prevalence and use of thiazolidinediones: results from the Vermont diabetes Information System
- Association between consumption of dairy products and incident type 2 diabetes—insights from the European Prospective Investigation into cancer study
- Association between diabetes and cancer in Indian and US Populations using Longitudinal Study Design
- Association between diabetes and colorectal cancer risk in a homogeneous canadian population
- Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population
- Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer
- Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
- Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature
- Association between diabetes mellitus and kidney cancer
- Association between diabetes mellitus and lung cancer: meta‐analysis
- Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy
- Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies
- Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
- Association between diabetes, diabetes treatment and risk of developing endometrial cancer
- Association between diagnosed diabetes and self-reported cancer among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System
- Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
- Association between exposure to desalinated sea water and ischemic heart disease, diabetes mellitus and colorectal cancer; A population-based study in Israel
- Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies
- Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
- Association between metabolic syndrome, diabetes mellitus and prostate cancer risk
- Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review
- Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
- Association between metformin use and mortality after cervical cancer in older women with diabetes
- Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population …
- Association between pancreatic cancer and metformin use in patients with type 2 diabetes
- Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: a long-term historical cohort study …
- Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes
- Association Between Statins and cancer Incidence in diabetes: a Cohort Study of Japanese Patients with Type 2 diabetes
- Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses
- Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013
- Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study
- Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
- Association between type 2 diabetes mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC).
- Association between type 2 diabetes mellitus risk factors with breast cancer in Mexican women
- Association between type 2 diabetes, curative treatment and survival in men with intermediate‐and high‐risk localized prostate cancer
- Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake
- Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
- Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective …
- Association of Adipose Tissue Distribution With Type 2 diabetes in Breast cancer Patients
- ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITH cancer RISK IN PATIENTS WITH TYPE 2 diabetes MELLITUS
- Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
- Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality
- Association of breast cancer and diabetes mellitus in Korean postmenopausal women
- Association of Comorbid diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal cancer Survivors.
- Association of Delta-6-Desaturase expression with aggressiveness of cancer, diabetes mellitus, and multiple sclerosis: a narrative review
- Association of diabetes and cancer mortality in American Indians: the Strong Heart Study
- Association of diabetes and cancer-diagnoses in primary care practices in Germany.
- Association of diabetes and diabetes treatment with incidence of breast cancer
- Association of diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast cancer Treatment for Breast cancer
- Association of diabetes and perineural invasion in pancreatic cancer
- Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
- Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer
- Association of diabetes mellitus with biological behaviors of colorectal cancer
- Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer.
- Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population
- Association of diabetes mellitus with prostate cancer: nested case–control study (Prostate testing for cancer and treatment study)
- Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
- Association of diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung cancer: a Retrospective Study in Japan
- Association of diabetes Susceptibility Gene Calpain-10 with Pancreatic cancer Among Smokers
- Association of diabetes with colorectal cancer treatment and outcomes.
- Association of diabetes with colorectal cancer treatment and outcomes.
- Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
- Association of diabetes with oral cancer-an enigmatic correlation
- Association of diabetes with perineural invasion and overall survival in surgically resected patients with pancreatic cancer.
- Association of diabetes with prostate cancer risk in the multiethnic cohort
- Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer
- Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer
- Association of endometrial hyperplasia and cancer with a history of gestational diabetes
- Association of endometrial hyperplasia or cancer with a history of gestational diabetes-results from a population-based study in Washington State, 1987-2013
- association of Family history of Type 2 diabetes with Prostate cancer: a national cohort study
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
- Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
- Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis
- Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: a GRADE-assessed systematic review and meta-analysis
- Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon cancer in Patients With Type 2 diabetes
- Association of serum anti-gad antibody and hla haplotypes with type 1 diabetes mellitus triggered by nivolumab in patients with non–small cell lung cancer
- Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes
- Association of serum paraoxonase 1 activities, polymorphisms and oxidative stress in breast cancer patients with type 2 diabetes mellitus
- Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
- Association of the consumption of common food groups and beverages with mortality from cancer, ischaemic heart disease and diabetes mellitus in Serbia, 1991 …
- Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes
- Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case–control study
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women
- Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
- Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review
- Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate cancer Cohort Consortium
- Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people
- Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the …
- Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
- Associations between diabetes and quality of life among breast cancer survivors
- Associations between diabetes medication use and risk of second breast cancer events and mortality
- Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian diabetes, Obesity and Lifestyle Study
- Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
- Associations of hemoglobin A1c with risk of diabetes-related cancers in the cancer Prevention Study-II Nutrition Cohort (CPS-II NC)
- Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
- Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
- Associations of Telomere Length and diabetes with Pancreatic cancer
- Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
- Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer
- At the intersection of diabetes and cancer: the role of angiogenesis and inflammation
- Atezolizumab-induced autoimmune diabetes in a patient with metastatic lung cancer
- Atrial natriuretic peptide and type 2 diabetes development, evidence of causal association from the prospective Malmö diet and cancer study
- Attitude toward death in healthy people and patients with diabetes and cancer
- Attitudes, perceptions, and family coping in pediatric cancer and childhood diabetes
- Atypical diabetes insipidus in small cell lung cancer: paraneoplastic syndrome or metastatic disease?
- Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells
- Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
- Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, diabetes, Breast and Prostate cancer
- Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer
- Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer
- Automatic Extraction of Useful Information from Food-Health Articles related to diabetes, Cardiovascular Disease and cancer
- Award of the Foundation for the State of Kuwait Prize for the Control of cancer, Cardiovascular Diseases and diabetes in the Eastern Mediterranean Region
- Bamboo extract in the prevention of diabetes and breast cancer
- Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the ‘cerebral diabetes paradigm’
- Benefits of screening for pancreatic cancer in new-onset diabetes mellitus
- BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer
- Beyond diabetes mellitus: role of metformin in non-muscle invasive bladder cancer
- Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
- Bio-Inspired and Nanotechnology-Enabled Drug Delivery for diabetes and Brain cancer
- Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope for diabetes and cancer
- Biochemical mechanisms connecting diabetes and cancer. Effects of methormine
- Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overview
- Biologic evaluation of diabetes and local recurrence in non-small cell lung cancer
- Biology of circulating nucleic acids and possible roles in diagnosis and treatment in diabetes and cancer.
- Bitter melon as a therapy for diabetes, inflammation, and cancer: a panacea?
- Bittergourd (Momordica charantia) scavenges free radicals by enhancing the expression of superoxide dismutase in in vitro models of diabetes and cancer
- Blacks more likely to die of cancer and diabetes
- Bladder cancer In Patients With Type 2 diabetes Treated With Pioglitazone, A Comparative Study
- Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis
- BMI and weight: their relation to diabetes, CVD, cancer and allcause mortality
- Body fat distribution, diabetes, and prostate cancer in Afro-Caribbean men: the Tobago Prostate cancer Survey
- Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam study
- Body mass index and cancer risk among Chinese patients with type 2 diabetes mellitus
- Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
- Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
- Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis
- Body mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancer
- Body mass index and obesity-related cancer risk in men and women with type 2 diabetes (ZODIAC-56)
- Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center diabetes Database
- Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)–Potsdam Study–
- Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver cancer pooling project and meta-analysis
- Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-Survey
- Body mass index, diabetes, and triple-negative breast cancer prognosis
- Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study …
- Body mass index, type 2 diabetes, and insulin prescription in adolescents and young adults with cancer
- Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults
- Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
- Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
- Breast and prostate cancer survivors in a diabetic cohort: results from the Living with diabetes Study
- Breast cancer and diabetes mellitus
- Breast cancer and diabetes mellitus: Complex interactions
- Breast cancer and diabetes.
- Breast cancer in women with diabetes mellitus type 2
- Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
- Breast cancer increases diabetes risk
- Breast cancer patients with diabetes mellitus: Defining the population and assessing outcomes.
- Breast cancer Radiotherapy Associated diabetes Mellitus Case Reports
- Breast cancer resistance protein and diabetes
- Breast cancer with diabetes insipidus
- Breast cancer, diabetes mellitus and usefulness of immunonutrition
- Breast cancer: Increased Risk of Cardiotoxicity Found with Trastuzumab for Elderly Patients with Heart Disease, diabetes
- Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
- Brief report: the risk of posttraumatic stress disorder in mothers of children diagnosed with pediatric cancer and type I diabetes
- Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation
- Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030
- Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors
- Burden of diabetes and oral cancer in India
- Burden of diabetes in cancer inpatients
- Burden of Health Disparities in Chronic Illnesses: A Report on Cardiovascular Disease, diabetes, and cancer in La Crosse County
- Cadmium exposure and incidence of diabetes mellitus-results from the Malmö Diet and cancer study
- Can a diabetes Drug Prevent cancer Death?
- Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort study
- Can diabetes Change the Intrinsic Subtype Specificity of Breast cancer
- Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models
- Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
- Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2
- Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol
- cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
- cancer among patients with type 2 diabetes mellitus: a population-based cohort study in northeastern Italy
- cancer and cholesterol: understanding the V-shaped association in patients with diabetes
- cancer and diabetes
- cancer and diabetes
- cancer and diabetes
- cancer and diabetes mellitus a review of the literature
- cancer and diabetes mellitus based on autopsy data
- cancer and diabetes‐a follow‐up study of two populationbased cohorts of diabetic patients
- cancer and diabetes, an increasing common combination: Improving knowledge among oncology nurses.
- cancer and diabetes: are there similarities?
- cancer and diabetes: are we ready for prime time?
- cancer and diabetes: new links and new challenges
- cancer and diabetes: two pathological conditions in which adrenomedullin may be involved
- cancer as a metabolic disease and diabetes as a cancer risk?
- cancer biology and prevention in diabetes
- cancer biology in diabetes
- cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment,
- cancer detection rates following enrolment in a disease management programme for type 2 diabetes
- cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population‐based study (The Ayrshire diabetes …
- cancer in diabetes patients: Basing a wrong conclusion on a wrong or on a correct analyses.
- cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
- cancer in south Karnataka and its paradoxical relation to diabetes mellitus
- cancer incidence among Finnish people with type 2 diabetes during 1989–2014
- cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
- cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
- cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai
- cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
- cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden
- cancer incidence in patients with type 2 diabetes mellitus in Minhang District of Shanghai
- cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
- cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
- cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.
- cancer incidence in type 1 diabetes: A 5-country study of 9,000 cancers in type 1 diabetic individuals Electronic Supplementary Material
- cancer incidence in type 2 diabetes patients-first results from a feasibility study of the D2C cohort
- cancer morbidity in patients with diabetes mellitus
- cancer of the breast, diabetes and pathological glucose tolerance
- cancer of the organs of the reproductive system in women with type 2 diabetes. Effects of antidiabetic therapy
- cancer of unknown primary is associated with diabetes
- cancer Patients with Undiagnosed and Poorly Managed diabetes Mellitus
- cancer patients with undiagnosed and poorly managed diabetes mellitus.
- cancer prediction for type-2 diabetes using machine learning
- cancer prevention with a diabetes pill?
- cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data …
- cancer recording in patients with type 2 diabetes in primary care and hospital admission data: IJPDS (2017) Issue 1, Vol 1: 314 Proceedings of the IPDLN …
- cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population‐based cohort study in Sweden
- cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
- cancer risk among patients with type 2 diabetes: A real‐world study in Shanghai, China
- cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
- cancer risk associated with insulin glargine among adult type 2 diabetes patients–a nationwide cohort study
- cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis
- cancer risk due to type 2 diabetes
- cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis
- cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data
- cancer risk in dialyzed patients with and without diabetes
- cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
- cancer risk in patients with diabetes mellitus
- cancer risk in patients with type 2 diabetes mellitus and their relatives
- cancer Risk in Patients with Type 2 diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
- cancer risk in people with diabetes: does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway
- cancer risk in people with type 1 and type 2 diabetes in Australia
- cancer risk in type 2 diabetes
- cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations
- cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows
- cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
- cancer risks from diabetes therapies: evaluating the evidence
- cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment–a clinical appraisal
- cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
- cancer Signaling Transcriptome Is Upregulated in Type 2 diabetes Mellitus
- cancer specific mortality in insulin-treated type 2 diabetes patients
- cancer stem cells generated by alcohol, diabetes, and hepatitis C virus
- cancer susceptibility in two rat models of spontaneous diabetes
- cancer treatment and cellular stress induced type 2 diabetes mellitus
- cancer with diabetes: Prevalence, metabolic control, and survival in a general oncology practice.
- cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice
- cancer-related side effects and diabetes self-management.
- cancer-suppressing enzyme adds a link to type 2 diabetes
- cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer
- cancer, diabetes, and angiotensin blockade: a question of hypohydration.
- cancer, Heart Disease, and diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo- p -dioxin
- cancer, heart, and diabetes societies join to publicise uninsured Americans
- cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis
- cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
- cancer, type 2 diabetes, and ageing: news from flies and worms
- Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans
- Capnocytophaga sputigena pneumonia and bacteremia in a patient with diabetes and gastric cancer
- Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
- Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC-NL) study
- Cardiorespiratory fitness as a predictor of cancer mortality among men with pre-diabetes and diabetes
- Cardiovascular comorbidity and ovarian cancer patient survival: history of hypertension, heart disease, and diabetes, evidence from the Ovarian cancer Association …
- Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission
- Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory
- Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
- Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre‐existing diabetes: A nationwide study
- Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications
- Care of esophageal cancer patients with diabetes mellitus–preoperative management and treatment
- Care Plan for Resuming the Physical Activity of Patients With Pancreatic cancer and diabetes After Surgery
- CARING (cancer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants-a systematic review and a …
- Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
- Case report of severe Cushing’s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception …
- Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan
- Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women
- Causal Evaluation of Laboratory Markers in Type 2 diabetes on cancer and Vascular Diseases Using Various Mendelian Randomization Tools
- Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview
- Cause of death for those with diabetes and/or cancer provides further support for an important role of vitamin D in reducing risk of many types of disease
- Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication
- Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
- Causes of death in men with prevalent diabetes and newly diagnosed high-versus favorable-risk prostate cancer
- Central diabetes insipidus and Cushing’s syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report
- Central diabetes insipidus caused by pituitary metastasis of lung cancer
- Central diabetes insipidus caused by pituitary metastasis of lung cancer
- Central diabetes insipidus caused by pituitary metastasis of lung cancer
- Central diabetes Insipidus: An Unusual Initial Presentation of Lung cancer
- Ceritinib aggravates glycemic control in insulin-treated patients with diabetes and metastatic ALK-positive lung cancer
- Challenges and perspectives in the treatment of diabetes associated breast cancer
- Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lung cancer and diabetes Mellitus
- Challenges in the management of people with diabetes and cancer
- Challenges of imaging for cancer in patients with diabetes and obesity
- Change in the incidence of diabetes mellitus in oral cancer patients based on a long-term comparative study
- Changes in blood glucose of elderly patients with gastric cancer combined with type 2 diabetes mellitus after radical operation and the effect of mediation …
- Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
- Changes in intake of dairy product subgroups and risk of type 2 diabetes: modelling specified food substitutions in the Danish Diet, cancer and Health cohort
- Changes in medication management after a diagnosis of cancer among medicare beneficiaries with diabetes
- Changes on blood glucose of different operation scheme after gastrectomy for gastric cancer in patients complicated with diabetes mellitus
- Characteristics and prognosis of breast cancer patients with type-2 diabetes mellitus
- Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
- Characteristics of the clinical course of breast cancer in patients with diabetes mellitus
- Characteristics of treatment of patients with breast cancer and diabetes mellitus
- Characterizing hyperglycemia in cancer patients with diabetes in an Emergency Center
- Chemical Investigations of diabetes Mellitus, Malaria, and Castrate-Resistant Prostate cancer
- Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer
- Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis
- Childhood cancer Survivors Have More diabetes
- Childhood cancer, type 1 diabetes and other immune diseases: healthcare visits in the year before diagnosis in Taiwan
- Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case–control study
- Cholesterol drugs improve breast cancer prognosis in women with diabetes mellitus
- Christian Religious Coping with HIV, cancer, and diabetes: African American Women and the Church’s Response
- Chronic diseases and health care: new trends in diabetes, arthritis, osteoporosis, fibromyalgia, low back pain, cardiovascular disease, and cancer
- Chronic Low‐grade Inflammation in Obesity and diabetes associated Colorectal cancer Development.
- Chronic pancreatitis, type 3c diabetes, and pancreatic cancer risk
- Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.
- Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
- Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
- Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical …
- Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients
- Classification of cancer for Type 2 diabetes Using Machine Learning Algorithm
- Clinical analysis of breast cancer patients with type 2 diabetes mellitus in Xinjiang
- Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension
- Clinical challenges in caring for patients with diabetes and cancer
- Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus
- Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes
- Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer
- Clinical effects of postoperative early enteral nutrition for the gastric cancer patients with diabetes [J]
- Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China
- Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus
- Clinical improvement of diabetes mellitus type 1 by bD-mannuronic acid (M2000) in a breast cancer patient—as a case report
- Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor?
- Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
- Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study
- Clinical Research on the Relationship between Type 2 diabetes Mellitus and Colorectal cancer
- Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy
- Clinical significance of serum lncRNA cancer susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2 diabetes
- Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer
- Clinical study of cytidine deaminase in serum of cancer thalassemia and diabetes patients
- Clinical Translational Research: cancer, diabetes, and Cardiovascular Disease
- Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study
- Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
- Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes
- Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China
- Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus
- Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus
- Clinicopathological characteristics of colorectal cancer complicated with type 2 diabetes mellitus: analysis of clinicopathological data from 3, 202 colorectal cancer …
- Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer
- Clinicopathological features of pancreatic cancer-related diabetes.
- Close Relationship between diabetes and cancer
- Co-existing prostate cancer and diabetes mellitus: implications for patient outcomes and care
- Co-Managing Patients with Type 1 diabetes and cancer
- Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lung cancer: Impact of hypertension, diabetes and chronic hepatitis B …
- Co-occurrence of diabetes and breast cancer among women by ethnicity
- Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data
- Codon 72 polymorphisms of p53 are associated with obesity, diabetes, and race in breast cancer
- Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer
- Cohort profile: the Australian and New Zealand diabetes and cancer collaboration (ANZDCC)
- Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological cancer …
- Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes
- Cohort study of pioglitazone and cancer incidence in patients with diabetes
- Colon cancer Patients with diabetes Have Increased Risk of Recurrence
- Colorectal and prostate cancer risk in diabetes: metformin, an actor behind the scene
- Colorectal cancer and diabetes
- Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose.
- Colorectal cancer in patients with type 2 diabetes mellitus: A single-center experience
- COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY
- Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis
- Colorectal cancer Risks According to Sex Differences in Patients With Type II diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
- Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics
- Colorectal cancer, diabetes and survival: epidemiological insights
- Colorectal cancer: another complication of diabetes mellitus?
- Colorectal cancer: Histopathologic differences in tumor characteristics between patients with and without diabetes
- Combination of type 2 diabetes and smoking increases total cancer mortality in Japanese men using competing risk analysis: the Tanno-Sobetsu study
- Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
- Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
- Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
- Comment A turning point for chronic kidney disease in diabetes Perioperative FLOT: new standard for gastric cancer?
- Comment on “Personal History of diabetes as Important as Family History of Colorectal cancer for Risk of Colorectal cancer: A Nationwide Cohort Study”
- Comment on Andersen et al, Pancreatitis–diabetes–Pancreatic cancer: Summary of an NIDDK-NCI Workshop
- Comment on: Need for Differentiating diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding cancer Survival
- Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124–129
- Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. diabetes Care 2012; 35: 2665–2673
- Comment on: Suissa and Azoulay. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
- Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35: 2500–2502
- Commentary on “Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus.” Kalakota K, Liauw SL …
- Comments on” Use of metformin and risk of kidney cancer in patients with type 2 diabetes“, Chin-Hsiao Tseng, Eur J cancer, 2016, No. 52, pp. 19-25.
- Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm
- Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature
- Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study
- Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer
- Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes
- Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study
- Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes
- Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus
- Comparing Survival Functions with Doubly Interval-Censored Data: An Application to diabetes Surveyed by Korean cancer Prevention Study
- Comparing the patterns of hypertension and type 2 diabetes mellitus in patients with colorectal cancer
- Comparison of AIS and fuzzy c-means clustering methods on the classification of breast cancer and diabetes datasets
- Comparison of Bee and BMI Based on Charted Versus Measured Height and Weight of diabetes Mellitus and cancer Patients
- Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey
- Comparison of Health Hardness and Life Expectancy in Patients with diabetes and Breast cancer
- Competing interests in a lung cancer with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versus diabetes insipidus
- Complete Healing from cancer diabetes Leukemia and Other Chronic Disorders
- Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity, diabetes and cancer
- Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer
- Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
- Confounding Factors of the diabetes-Metformin-cancer Relationship
- Connecting the Dots Between Obesity, diabetes and cancer
- Considerations for developing chronic care system for traumatic brain injury based on comparisons of cancer survivorship and diabetes management care
- Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: from concept to reality
- Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
- Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening
- Contribution of diabetes to the incidence and prevalence of comorbid conditions (cancer, periodontal disease, fracture, impaired cognitive function, and depression): a …
- Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings …
- Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the …
- Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications of diabetes on breast cancer classification.
- Controversies Related to diabetes and Risk of Bladder cancer.
- Controversy regarding gastric cancer and diabetes
- Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis
- Convergence and divergence of genetic and modular networks between diabetes and breast cancer
- Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and cancer Study cardiovascular cohort
- Correction to: Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
- Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.
- Correction: Sex-specific Association between Family History of diabetes and Risk of Colorectal cancer: Two Prospective Cohort Studies
- Correction: Survival Benefits of Metformin for Colorectal cancer Patients with diabetes: A Systematic Review and Meta-Analysis
- Correlates Between Colorectal cancer Screening and diabetes Mellitus Among Residents of Ohio Appalachia: 1455
- Correlation between blood glucose level and the prognosis of postoperative pancreatic cancer patients with diabetes
- Correlation between BMI, diabetes Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder cancer
- Correlation Between Body Mass Index, diabetes and Outcome in a Cohort of Egyptian Early Breast cancer Patients
- Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: insights from metanalysis of transcriptomics data
- Correlation between diabetes prevalence and subsequent cancer mortality in North Carolina counties
- Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data
- Correlation between treatment of diabetes mellitus and development cancer
- Correlations of microRNA-124a and microRNA-30d with clinicopathological features of breast cancer patients with type 2 diabetes mellitus
- Cost-effectiveness of adjuvant therapy for treatment of stage II colon cancer in patients with diabetes.
- Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
- Critical role of Dipeptidyl Peptidase IV: A therapeutic target for cancer & diabetes
- Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer
- Cullin-1 promotes cell proliferation in human breast cancer and is related to diabetes
- Cultural worldviews and perceived risk of colon cancer and diabetes
- Current drug information: Pioglitazone associated with increased risk of bladder cancer among people with type 2 diabetes
- Current drug information: Thiazolidinediones associated with increased risk of bladder cancer among adults with type 2 diabetes
- Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
- Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis
- Cytokine synergism in apoptosis: its role in diabetes and cancer
- Cytokines in the interface of metabolomics based cancer and type-2 diabetes
- Cytolysis and karyopyknosis in postmenopausal vaginal smears as markers of endometrial cancer, diabetes and obesity. Studies based on a ten-year follow-up.
- Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration
- Dapagliflozin Protects Doxorubicin-induced Cardiotoxicity in Breast cancer Patients With diabetes via Suppressing ER Stress
- Data mining applications to dermatological diseases, colorectal cancer, diabetes, cardiology and medical audit systems
- Data mining Twitter for cancer, diabetes, and asthma insights
- Data on BMI, diabetes mellitus and non-muscle invasive bladder cancer recurrence and progression from the Nijmegen Bladder cancer study conducted in The …
- Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
- Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
- Death by lung cancer or by diabetes? The unintended consequences of quitting smoking
- Debating cancer and diabetes in Vienna
- Decavanadate salts of cytosine and metformin: a combined experimental-theoretical study of potential metallodrugs against diabetes and cancer
- Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
- Deciphering the scalene association among type‐2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease‐gene …
- Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study
- Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study
- Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus
- Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
- Defective Lipolysis In diabetes And cancer
- Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease
- Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
- Delivery of small molecule and RNA for the treatment of type 1 diabetes and prostate cancer
- Demodex species positivity among patients with cancer, on hemodialysis and with diabetes mellitus
- Demographic changes in the burden of diabetes and cancer
- Demographic Characteristics, Survival and Prognostic Factors of Early Breast cancer Patients with Type 2 diabetes Mellitus: A Hospital-Based Cohort Study
- Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study
- Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated cancer Patients with Type 2 diabetes Mellitus
- Determination of polymorphism of K-ras and DPC4 genes in pancreatic cancer in the background of diabetes mellitus
- Determining the Impact of a cancer Diagnosis on diabetes Management: A Systematic Literature Review
- Developing a clinical and genetic risk prediction model for diabetes mellitus among survivors of childhood cancer
- Development and characterisation of a multifunctional hybrid nano-flora composite for the prevention and management of cancer, diabetes, blood pressure and …
- Development of a prediction model for colorectal cancer among patients with type 2 diabetes mellitus using a deep neural network
- Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
- Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network
- Development of the national Expected Screening Rate for cardiovascular disease, type 2 diabetes, cervical cancer and colorectal cancer as a benchmark for …
- Development of the RapidMist drug delivery system for the treatment of diabetes, cardiovascular diseases and breakthrough cancer pain
- Development of type 1 diabetes after cancer immunotherapy
- Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
- Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity
- diabetes after hormone therapy in breast cancer survivors: a case-cohort study
- diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
- diabetes and adiposity: a heavy load for cancer
- diabetes and altered carbohydrate metabolism in patients with cancer
- diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
- diabetes and body mass index are associated with neuropathy and prognosis in colon cancer patients treated with capecitabine and oxaliplatin adjuvant …
- diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
- diabetes and breast cancer in T aiwanese women: a detection bias?
- diabetes and breast cancer mortality in Black women
- diabetes and breast cancer risk in a population-based case-control study of Hispanic and white, non-Hispanic women living in US Southwestern states
- diabetes and breast cancer risk: a meta-analysis
- diabetes and breast cancer subtypes
- diabetes and breast cancer: the women’s healthy eating & living study
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer
- diabetes AND cancer
- diabetes and cancer
- diabetes and cancer
- diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
- diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
- diabetes AND cancer AMONG VETERANS
- diabetes and cancer I: risk, survival, and implications for screening
- diabetes and cancer II: role of diabetes medications and influence of shared risk factors
- diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia
- diabetes and cancer mortality: a multifaceted association
- diabetes and cancer risk for all and specific sites among Japanese men and women
- diabetes and cancer risk in the REDUCE trial.
- diabetes and cancer risk: A Mendelian randomization study
- diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky
- diabetes and cancer screening: a win-win situation or a zero game?
- diabetes and cancer Screening: A Win-Win Situation or a Zero Game?—Reply
- diabetes and cancer-a dangerous liaison?
- diabetes and cancer-Related Mechanisms.
- diabetes and cancer—an AACE/ACE consensus statement
- diabetes and cancer, common threads and missing links
- diabetes and cancer: 5 years into the recent controversy
- diabetes and cancer: a 2013 synopsis
- diabetes and cancer: A comprehensive review
- diabetes and cancer: a consensus report
- diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links
- diabetes and cancer: a postulated relationship
- diabetes and cancer: a review of current knowledge
- diabetes and cancer: an injurious association
- diabetes and cancer: Associations, mechanisms, and implications for medical practice
- diabetes and cancer: cancer should be screened in routine diabetes assessment
- diabetes and cancer: could vitamin D provide the link?
- diabetes and cancer: Debating the link through Ca2+/cAMP signalling
- diabetes and cancer: Epidemiologic and physiopathogenic links
- diabetes and cancer: epidemiological and biological links
- diabetes and cancer: Epidemiological evidence and molecular links
- diabetes and cancer: Epidemiological Evidence and Molecular Links
- diabetes and cancer: Epidemiological Evidence and Molecular Links Series [Book Review]
- diabetes and cancer: epidemiological, clinical, and experimental perspectives
- diabetes and cancer: Epidemiological, Clinical, and Experimental Perspectives
- diabetes and cancer: epidemiology and potential mechanisms
- diabetes and cancer: Evidence for Risk, Methodology and Implications
- diabetes and cancer: findings from the REACTION study: REACTION.
- diabetes and cancer: impact on health-related quality of life
- diabetes and cancer: is diabetes causally related to cancer?
- diabetes and cancer: Is there a Link?
- diabetes and cancer: looking at the multiligand/RAGE axis
- diabetes and cancer: pathophysiological fundamentals of a ‘dangerous affair’
- diabetes and cancer: placing the association in perspective
- diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong diabetes Registry
- diabetes and cancer: The Problem of Reverse Causality and Missing Links
- diabetes and cancer: The Road Ahead
- diabetes and cancer: two diseases with obesity as a common risk factor
- diabetes and cancer: Unraveling the Complexity
- diabetes and cancer.
- diabetes AND cancer.
- diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
- diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer
- diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
- diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer
- diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance)
- diabetes and colorectal cancer incidence in the cohort of Swedish men
- diabetes and colorectal cancer prognosis: a meta-analysis
- diabetes and colorectal cancer screening among men and women in the USA: National Health Interview Survey: 2008, 2010
- diabetes And Colorectal cancer: Could Ampk Signaling Pathway Explains The Link?
- diabetes and differences in detection of incident invasive breast cancer
- diabetes and endometrial cancer
- diabetes and endometrial cancer in the Iowa women’s health study
- diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors
- diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors.
- diabetes and endometrial cancer: an Italian case‐control study
- diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension
- diabetes and gastric cancer: the potential links
- diabetes and hyper-insulinemia as predictors of colorectal cancer risk in a prospective cohort of women
- diabetes and infarcted papillary thyroid cancer.
- diabetes and insulin therapy, but not metformin, are related to hepatocellular cancer risk
- diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime
- diabetes and its relationship with pancreatic cancer
- diabetes and kidney cancer outcomes: a propensity score analysis
- diabetes and kidney cancer risk among post-menopausal women: The Iowa women’s health study
- diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
- diabetes and kidney cancer: A direct or indirect association?
- diabetes and liver cancer risk: A stronger effect in Whites than Blacks?
- diabetes and lung cancer among postmenopausal women
- diabetes and metabolic syndrome in survivors of childhood cancer
- diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast cancer Patients
- diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92–02
- diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
- diabetes and mortality in patients with prostate cancer: a meta-analysis
- diabetes and Obesity and Their Association with Increased Acute Urinary Symptoms in Prostate cancer Patients After Receiving Interstitial LDR Brachytherapy
- diabetes AND OBESITY INDUCE TRANSCRIPTOMIC AND METABOLOMIC CHANGES ENHANCING PANCREATIC cancer AGGRESSIVENESS
- diabetes and onset of natural menopause: results from the European Prospective Investigation into cancer and Nutrition
- diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast cancer Survivorship Consortium (CBCSC)
- diabetes AND OUTCOMES AFTER RADICAL PROSTATECTOMY-ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL …
- diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database
- diabetes and overall survival among breast cancer patients in the US military health system
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer
- diabetes and pancreatic cancer survival: a prospective cohort study
- diabetes and pancreatic cancer survival: a prospective cohort-based study
- diabetes and Pancreatic cancer—A Dangerous Liaison Relying on Carbonyl Stress
- diabetes and Pancreatic cancer: A Bidirectional Relationship Perspective
- diabetes and pancreatic cancer: both cause and effect
- diabetes and pancreatic cancer: chicken or egg?
- diabetes and Pancreatic cancer: Reply
- diabetes and prognosis in a breast cancer cohort
- diabetes and prognosis in older persons with colorectal cancer
- diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes
- diabetes and Prostate cancer Aggressiveness at Diagnosis and Progression in White Americans and Black Americans from the North Carolina-Louisiana Prostate …
- diabetes and prostate cancer risk in the REDUCE trial
- diabetes and prostate cancer screening in black and white men
- diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
- diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- diabetes and risk of bladder cancer: evidence from a case‐control study in New England
- diabetes and risk of breast cancer in Asian-American women
- diabetes and risk of cancer
- diabetes and risk of cancer
- diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
- diabetes and risk of early-onset colorectal cancer
- diabetes and Risk of Endometrial cancer: a Meta-analysis [J]
- diabetes and risk of endometrial cancer: a population-based prospective cohort study
- diabetes and risk of incident cancer: a large population-based cohort study in Israel
- diabetes and risk of incident colorectal cancer in a prospective cohort of women
- diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
- diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
- diabetes and risk of prostate cancer in a prospective cohort of US men
- diabetes and risk of prostate cancer: a study using the National Health Insurance
- diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
- diabetes and sex-specific colorectal cancer risks in Newfoundland and Labrador: a population-based retrospective cohort study
- diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland–A 15‐year follow up study
- diabetes and the cancer Patient
- diabetes and the Development of Pancreatic cancer [J]
- diabetes and the risk for colorectal cancer
- diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
- diabetes and the Risk of cancer Death: A Case-Cohort Study in Taiwanese Men
- diabetes and the risk of death in men with favorable or high-risk prostate cancer following radiation therapy
- diabetes and the risk of lung cancer
- diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European Prospective Investigation into cancer and Nutrition.
- diabetes and the risk of pancreatic cancer
- diabetes and the risk of pancreatic cancer
- diabetes and the risk of prostate cancer
- diabetes and the risk of prostate cancer: the role of diabetes treatment and complications
- diabetes and Thyroid cancer in Chinatown: Diversity and Acculturation
- diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of Taiwanese
- diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study
- diabetes and thyroid cancer risk: literature review
- diabetes and urothelial cancer risk: the Multiethnic Cohort study
- diabetes as a predictor of colon cancer prognosis: A single institution based retrospective data analysis.
- diabetes as a presenting feature of pancreatic cancer: A case report
- diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy
- diabetes as a Risk Factor for Breast cancer
- diabetes as a risk factor for death following endometrial cancer
- diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population
- diabetes as a risk factor of pancreatic cancer
- diabetes as a risk factor to cancer: Functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer
- diabetes as Independent Risk Factor for cancer after Heart and Lung Transplantation
- diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
- diabetes associated with abnormal p53 immunohistochemical patterns in colorectal cancer
- diabetes associated with short survival in pancreatic cancer
- diabetes association of polyps and colon cancer.
- diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study
- diabetes but not insulin is associated with higher colon cancer mortality
- diabetes care after cancer diagnosis in patients with type 2 diabetes and colorectal-or breast cancer treated with curative intent
- diabetes care management during cancer treatment.
- diabetes Care Management in the cancer Center: Challenging Current Models of Care to Optimize Outcomes for a Complex Population
- diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study
- diabetes Comorbidity and All-Cause, Cardiovascular, and cancer Mortality in US Adults
- diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan
- diabetes Could Be a Warning Sign of Pancreatic cancer: A Case Report and Literature Review
- diabetes decreases FDG accumulation in primary lung cancer
- diabetes drug helps towards immunity against cancer
- diabetes drug is linked with bladder cancer risk
- diabetes drug may be associated with increase in risk of bladder cancer
- diabetes Genes and Prostate cancer in the Atherosclerosis
- diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study
- diabetes has protective effect against metastasis in patients with non-small cell lung cancer
- diabetes in cancer Patients: Risks, Goals and Management
- diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)–Medicare …
- diabetes in midlife and risk of cancer in late life: a nationwide Swedish twin study
- diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China
- diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
- diabetes increases risk of gastric cancer after Helicobacter pylori eradication: a territory-wide study with propensity score analysis
- diabetes increases the risk of breast cancer: a meta-analysis
- diabetes increases the risk of colorectal cancer in Puerto Rico
- diabetes increases the risk of liver, pancreas, and gastric cancer among the Puerto Rican population
- diabetes influences cancer risk in patients with increased carotid atherosclerosis burden
- diabetes insipida por cancer de pulmon
- diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer
- diabetes insipidus and anterior pituitary insufficiency due to breast cancer metastasis
- diabetes insipidus and breast cancer
- diabetes insipidus and breast cancer-planning radiotherapy by the use of MRT
- diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer
- diabetes insipidus as a main symptom of cancer
- diabetes insipidus as the first symptom caused by lung cancer metastasis to the pituitary glands: clinical presentations, diagnosis, and management
- diabetes insipidus as the initial symtom in a patient with lung cancer: Case report
- diabetes insipidus caused by isolated intracranial metatstases in patient with breast cancer
- diabetes insipidus caused by pituitary gland metastasis accompanied by iris metastasis of small cell lung cancer: case presentation and review of the literature
- diabetes insipidus due to pituitary metastasis from bladder cancer
- diabetes insipidus due to pituitary metastasis of breast cancer
- diabetes insipidus in a patient with small-cell lung cancer: a paradox?
- diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer
- diabetes is an important risk factor for metastasis in non-muscle-invasive bladder cancer
- diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico
- diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer
- diabetes Is Associated With Socioeconomic Disparities and More Comorbidities in Colorectal cancer Surgery: A Nationwide Inpatient Sample Study: 2041
- diabetes is not a predisposing factor for pancreatic cancer-new evidence
- diabetes Is Not Associated With Longer Survival in Patients With Lung cancer—Reply
- diabetes management and self-care education for hospitalized patients with cancer
- diabetes Management and Self-Care Education for Hospitalized Patients With cancer
- diabetes management before and after cancer diagnosis: missed opportunity
- diabetes management in cancer patients
- diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway
- diabetes May Increase Women’s Risk Of Developing Colorectal cancer
- diabetes medication use in association with survival among patients of breast, colorectal, lung, and gastric cancer
- diabetes medication use in association with survival among patients of breast, colorectal, lung, or gastric cancer
- diabetes medications and cancer risk: review of the literature
- diabetes medications and cancer: A way out of uncertainty
- diabetes Medications, Prostate-Specific Antigen Values, and the Chemoprevention of Prostate cancer
- diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
- diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer
- diabetes mellitus among cancer survivors
- diabetes mellitus and age are risk factors of interval colon cancer: a case-control study
- diabetes mellitus and bladder cancer—an epidemiological relationship?
- diabetes mellitus and breast cancer
- diabetes mellitus and breast cancer
- diabetes mellitus and breast cancer
- diabetes MELLITUS AND BREAST cancer OUTCOMES
- diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis
- diabetes mellitus and breast cancer: a retrospective population-based cohort study
- diabetes mellitus and breast cancer. A retrospective follow-up study
- diabetes mellitus and cancer
- diabetes mellitus and cancer
- diabetes Mellitus and cancer
- diabetes mellitus and cancer in Werner syndrome
- diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study
- diabetes mellitus and cancer of the digestive organs: an Italian population-based cohort study
- diabetes mellitus and cancer risk in a network of case-control studies
- diabetes mellitus and cancer risk in a population‐based case–controlstudy among men from Montreal, Canada
- diabetes mellitus and cancer risk: a multisite case-control study
- diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan
- diabetes mellitus and cancer risk: review of the epidemiological evidence
- diabetes mellitus and cancer: the different expression of these diseases in Israeli Arabs and Jews
- diabetes mellitus and cancer.
- diabetes mellitus and carbohydrate metabolism in patients with cancer
- diabetes Mellitus and Colorectal cancer Risk
- diabetes mellitus and colorectal cancer risk.
- diabetes mellitus and colorectal cancer–a revealed connection
- diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study
- diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives
- diabetes mellitus and HbA1c levels associated with high grade prostate cancer
- diabetes mellitus and health‐related quality of life in prostate cancer: 5‐year results from the Prostate cancer Outcomes Study
- diabetes Mellitus and Hypertension are Risk Factor for Endometrial cancer
- diabetes mellitus and hypertension increase the risk of colorectal cancer mortality; a robust Bayesian adjustment analysis
- diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
- diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis
- diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis
- diabetes Mellitus and Incidence of Bladder and Kidney cancer: An Exposure-Control Matched Study
- diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
- diabetes Mellitus and Incident Gastroenteric cancer
- diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
- diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs
- diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of cancer Risk (JACC Study)
- diabetes mellitus and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population
- diabetes mellitus and long‐term mortality of ovarian cancer patients. A systematic review and meta‐analysis of 12 cohort studies
- diabetes Mellitus and Metformin Are Not Associated With Breast cancer Pathologic Complete Response
- diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health …
- diabetes mellitus and obesity among participants receiving screening for cancer in the Republic of the Marshall Islands
- diabetes mellitus and obesity as risk factors for pancreatic cancer
- diabetes Mellitus and Oral cancer: Are They Connected?
- diabetes Mellitus and Oral cancer: Is There a Causal Association?
- diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta‐analysis
- diabetes mellitus and outcomes of colorectal cancer
- diabetes mellitus and ovarian cancer (Sweden)
- diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies
- diabetes mellitus and ovarian cancer: More complex than increasing risk
- diabetes mellitus and ovarian cancer: more complex than just increasing risk
- diabetes mellitus and pancreas cancer
- diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
- diabetes mellitus and pancreatic cancer-cause or result?
- diabetes mellitus and pancreatic cancer-cause or result?
- diabetes mellitus and pancreatic cancer: a case-control study in Greater Montreal, Quebec, Canada
- diabetes Mellitus and Pancreatic cancer: A Risk Assessment
- diabetes mellitus and pancreatic cancer: why the association matters?
- diabetes mellitus and primary liver cancer: risk factor or real cause?
- diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis
- diabetes mellitus and prostate cancer metabolism: Is there a relationship?
- diabetes mellitus and prostate cancer risk
- diabetes mellitus and prostate cancer risk
- diabetes mellitus and prostate cancer risk among older men: population-based case–control study
- diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis
- diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian cancer Screening Trial
- diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis
- diabetes mellitus and prostate cancer risk; a nationwide case–control study within PCBaSe Sweden
- diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
- diabetes mellitus and risk of bladder cancer: a meta-analysis
- diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
- diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
- diabetes mellitus and risk of breast cancer: a meta‐analysis
- diabetes mellitus and risk of cancer in T akayama: A population‐based prospective cohort study in J apan
- diabetes mellitus and risk of cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy.
- diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study
- diabetes mellitus and risk of colorectal cancer mortality in Japan: the Japan Collaborative Cohort Study
- diabetes mellitus and risk of colorectal cancer: a meta-analysis
- diabetes mellitus and risk of endometrial cancer: a meta-analysis
- diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies
- diabetes mellitus and risk of kidney cancer: a meta-analysis
- diabetes mellitus and risk of large bowel cancer
- diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies
- diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies
- diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies
- diabetes mellitus and risk of prostate cancer (United States)
- diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition
- diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition.
- diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
- diabetes mellitus and risk of prostate cancer-A focus on shared risk factors and survivor bias
- diabetes mellitus and risk of prostate cancer: a meta-analysis
- diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
- diabetes mellitus and risk of thyroid cancer: a meta-analysis
- diabetes mellitus and site-specific colorectal cancer risk in Korea: a case-control study
- diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
- diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
- diabetes mellitus and survival after a diagnosis of breast cancer: A meta-analysis
- diabetes mellitus and survival of esophageal cancer patients after esophagectomy: a systematic review and meta-analysis
- diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis
- diabetes mellitus and the incidence and mortality of colorectal cancer: a meta‐analysis of 24 cohort studies
- diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis
- diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies
- diabetes Mellitus and the Risk for Developing cancer
- diabetes mellitus and the risk of bladder cancer: a PRISMA-compliant meta-analysis of cohort studies
- diabetes mellitus and the risk of bladder cancer: an Italian case–control study
- diabetes mellitus and the risk of cancer formation: Possible link and review of literature
- diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan
- diabetes mellitus and the risk of cancer.
- diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
- diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies
- diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
- diabetes mellitus and the risk of postmenopausal breast cancer: A retrospective population-based cohort study.
- diabetes mellitus and the risk of primary liver cancer
- diabetes mellitus and the risk of prostate cancer
- diabetes mellitus and the risk of prostate cancer in Italy
- diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
- diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
- diabetes mellitus as a result of pancreatic cancer
- diabetes mellitus as a risk factor for cancer: stress or viral etiology?
- diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans
- diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis
- diabetes mellitus as a risk factor for prostate cancer progression after radical prostatectomy in an Hispanic population
- diabetes Mellitus as a Risk Factor of Interval Colon cancer
- diabetes mellitus as a risk-factor for colorectal cancer literature review–current situation and future perspectives
- diabetes mellitus as an early symptom of pancreatic cancer diagnosed three years later
- diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies
- diabetes mellitus carries a risk of esophageal cancer: a meta-analysis
- diabetes mellitus carries a risk of gastric cancer: a meta-analysis
- diabetes mellitus correlates with increased risk of pancreatic cancer: a population‐based cohort study in Taiwan
- diabetes MELLITUS DOES NOT INCREASE THE RISK OF METASTATIC COLON cancer: A CASE CONTROL STUDY: 353
- diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
- diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
- diabetes mellitus in cancer patients treated with combination interleukin 2 and α-interferon
- diabetes mellitus in childhood and young adult cancer survivors: A meta-analysis.
- diabetes mellitus in long-term survivors of childhood cancer: increased risk associated with radiation therapy: a report for the childhood cancer survivor study
- diabetes mellitus in major head and neck cancer surgery
- diabetes mellitus in major head and neck cancer surgery: Systematic review and meta‐analysis
- diabetes mellitus in pancreatic cancer and the need for diagnosis of asymptomatic disease
- diabetes mellitus in pancreatic cancer follow-up.
- diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences
- diabetes mellitus in pancreatic cancer: is it a causal relationship?
- diabetes Mellitus in the Middle-Aged and Elderly Population (> 45 Years) and Its Association with Pancreatic cancer: An Updated Review
- diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients
- diabetes mellitus increases postoperative mortality in non-small cell lung cancer
- diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis
- diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies
- diabetes mellitus increases the risk of early gastric cancer development
- diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
- diabetes MELLITUS IS A RISK FACTOR FOR COLON cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 352
- diabetes MELLITUS IS A RISK FACTOR FOR PANCREATIC cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 168
- diabetes mellitus is an independent risk factor for colorectal cancer
- diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study
- diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
- diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta‐analysis of 11 cohort studies
- diabetes Mellitus is Associated with High Grade and High Stage in Urinary Bladder cancer
- diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma
- diabetes mellitus is associated with occult cancer in endometrial hyperplasia
- diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer
- diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
- diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases
- diabetes Mellitus raise the Risk for Interval Colorectal cancer and Advanced Colorectal Adenomas
- diabetes mellitus reduces prostate cancer risk-no function of age at diagnosis or duration of disease
- diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
- diabetes Mellitus Type 2 and Prolonged Exposure to Estrogen as Risk Factors for Development of Breast cancer in Women of Age 35-70 in Yerevan: A Case-Control …
- diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer
- diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
- diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung …
- diabetes mellitus type 2–an independent risk factor for cancer?
- diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
- diabetes Mellitus–A Prognostic Factor in Breast cancer?
- diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
- diabetes mellitus, family history, and colorectal cancer
- diabetes mellitus, genetic variants in the insulin‐like growth factor pathway and colorectal cancer risk
- diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into …
- diabetes mellitus, hyperglycaemia and cancer
- diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
- diabetes mellitus, metformin and head and neck cancer
- diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
- diabetes mellitus, other medical conditions and pancreatic cancer: a case‐control study
- diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy
- diabetes mellitus, race, and the odds of high-grade prostate cancer in men diagnosed with prostate cancer in the United States.
- diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal cancer Risk
- diabetes mellitus: a risk factor for pancreatic cancer?
- diabetes mellitus: A significant co‐morbidity in the setting of lung cancer?
- diabetes mellitus: influences on cancer risk
- diabetes outcomes in patients with a history of breast cancer.
- diabetes outcomes in patients with breast cancer.
- diabetes pharmacotherapies and bladder cancer: a medicare epidemiologic study
- diabetes Phenotypes in Transgenic Pancreatic cancer Mouse Models
- diabetes Plus Weight Loss Signals Increased Pancreatic cancer Risk
- diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats
- diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+ mice
- diabetes Protects from Prostate cancer by Downregulating
- diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model
- diabetes risk in childhood cancer survivors: a population-based study
- diabetes Self-Management among cancer Survivors: Differences by Diagnosis and Treatment
- diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
- diabetes therapies affect pancreatic cancer risk
- diabetes therapy and cancer risk: causal effects and other plausible explanations
- diabetes therapy and cancer risk: Where do we stand when treating patients?
- diabetes therapy and lung cancer
- diabetes Treatment and Risks of Adverse Breast cancer Outcomes Among Elderly Breast cancer Patients: A SEER-Medicare Analysis
- diabetes treatments and cancer risk: the importance of considering aspects of drug exposure
- diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis
- diabetes type 2 and pancreatic cancer: a history unfolding
- diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands
- diabetes-associated angiotensin activation enhances liver metastasis of colon cancer
- diabetes-related complications and pancreatic cancer incidence in the Multiethnic Cohort
- diabetes-Specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectal cancer
- diabetes–associated dysregulated cytokines and cancer
- diabetes, abnormal glucose, dyslipidemia, hypertension, and risk of inflammatory and other breast cancer
- diabetes, and Incident Colorectal cancer in Men and Women: A Prospective Analysis from the European Prospective Investigation into cancer–Norfolk Study
- diabetes, Antidiabetic Medications and cancer Risk in Type 2 diabetes: Focus on SGLT-2 Inhibitors
- diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
- diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
- diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
- diabetes, blood glucose lowering drugs and cancer risk
- diabetes, body fatness, and insulin prescription among adolescents and young adults with cancer
- diabetes, body size, and risk of endometrial cancer
- diabetes, breast cancer and mammographic density in the Minnesota breast cancer family study
- diabetes, cancer and iron
- diabetes, cancer and obesity: unequivocal association
- diabetes, cancer and treatment–a mini-review
- diabetes, cancer and weight: a Metabolic Typing survey
- diabetes, cancer Link Is New Research Focus
- diabetes, cancer, and metformin: connections of metabolism and cell proliferation
- diabetes, chronic kidney disease and cancer risk
- diabetes, colon cancer and Wnt beta-catenin signaling pathways
- diabetes, colorectal cancer and cyclooxygenase 2 inhibition
- diabetes, diabetes risk factors and treatments, and breast cancer
- diabetes, diabetes therapies and cancer: what’s the link?
- diabetes, diabetes treatment and breast cancer prognosis
- diabetes, diabetes treatment, and mammographic density in Danish Diet, cancer, and Health cohort
- diabetes, diabetes treatment, and risk of thyroid cancer
- diabetes, gall stone disease, and pancreatic cancer.
- diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms
- diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
- diabetes, Glycated Hemoglobin, and Risk of cancer in the UK Biobank Study
- diabetes, hypoglycemic drugs and pancreatic cancer
- diabetes, insulin and cancer risk
- diabetes, insulin and cancer risk The molecular role of insulin signaling and hyperinsulinemia in cancer development and progression in diabetes patients
- diabetes, insulin and cancer risk: you and your patient
- diabetes, Insulin Resistance, and cancer: An Update
- diabetes, insulin therapy, and colorectal cancer
- diabetes, insulin treatment, and cancer risk: what is the evidence?
- diabetes, insulin use, and cancer risk: are observational studies part of the solution–or part of the problem?
- diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese
- diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan
- diabetes, insulin-use and risk of colorectal cancer in a US cohort study
- diabetes, insulin, and risk of cancer
- diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
- diabetes, metformin and breast cancer: a tangled web
- diabetes, metformin and cancer risk in myotonic dystrophy type I
- diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: results from the women’s health initiative
- diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
- diabetes, metformin use, and colorectal cancer survival in postmenopausal women
- diabetes, metformin use, and colorectal cancer survival in women: A retrospective cohort study.
- diabetes, metformin, and breast cancer in postmenopausal women
- diabetes, Metformin, and Lung cancer: Retrospective Study of the Korean NHIS-HEALS Database
- diabetes, obesity and cancer: risk and anti-risk factors
- diabetes, obesity, and breast cancer
- diabetes, obesity, and cancer—pathophysiology and clinical implications
- diabetes, obesity, and subsequent risk of postmenopausal breast cancer among white and black women in the Southern Community Cohort Study
- diabetes, obesity, and survival in a large cohort of early-stage breast cancer patients.
- diabetes, obesity, and the metabolic syndrome as prognostic factors in stages I to III colorectal cancer patients
- diabetes, obesity, insulin resistance: different pathways to cancer?
- diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay
- diabetes, pancreatic cancer and vitamin D. Is there a link?
- diabetes, pancreatic cancer, and metformin therapy
- diabetes, pancreatogenic diabetes, and pancreatic cancer
- diabetes, physical activity and breast cancer among Hispanic women
- diabetes, physical activity and endometrial cancer
- diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people
- diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million C hinese adults and a meta‐analysis of 22 cohort studies
- diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people
- diabetes, prediabetes and cancer mortality
- diabetes, prostate cancer screening and risk of low-and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million …
- diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
- diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations
- diabetes, Weight Change, and Pancreatic cancer Risk
- diabetes: diabetes therapy and cancer risk
- diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease?
- Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report
- Diabetic Status after Radical Gastrectomy in Gastric cancer Patients with Type 2 diabetes Mellitus
- Diagnosing and monitoring endocrine dysfunction, diabetes, and obesity in a cohort of adult survivors of childhood cancer
- Diagnosis and survival of pancreatic cancer in relation to depression and diabetes history: A population-based study in Finland
- Diagnosis and treatment of 17 cases of pulmonary tuberculosis complicated by diabetes misdiagnosed lung cancer
- Diagnosis of Breast cancer and diabetes using Hybrid Feature Selection Method
- Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus
- Diastatic activity of the blood in cancer, syphilis and diabetes
- Diet quality and risk of type 2 diabetes: a prospective study in the Malmo Diet and cancer cohort
- Diet, diabetes and cancer–How and Why?
- Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of cancer (EPIC)-Norfolk Study
- Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of cancer-Norfolk study
- Dietary intake of carbohydrates and risk of type 2 diabetes: The European Prospective Investigation into cancer-Norfolk study
- Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-NL study
- Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition: the EPIC-InterAct study
- Differences in Biological Behavior of Colorectal cancer between Patients With and Without diabetes: 590
- Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
- Differences in Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Levels between Pancreatic cancer Patients with or Without diabetes Mellitus
- Different domains of self-reported physical activity and risk of type 2 diabetes in a population-based Swedish cohort: the Malmö diet and cancer study
- Differential expression and signaling activation of insulin receptor isoforms A and B: a link between breast cancer and diabetes
- Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes …
- Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases
- Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults
- Diminishing differences in treatment between colorectal cancer patients with and without diabetes: a population-based study
- Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population‐based study
- Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
- Discriminant, identifiable plasma metabolites in pancreatic cancer-associated diabetes-candidate early-detection biomarkers
- Discriminant, identifiable plasma metabolites in pancreatic cancer–associated diabetes.
- Discussion on the surgical treatment of cancer of esophageal and cardiac with diabetes——Clinical report of 31 cases
- Disease Detection Analytics: A Simple Linear Convex Programming Algorithm for Breast cancer and diabetes Incidence Decisions
- Disease-Proof: Slash Your Risk of Heart Disease, cancer, diabetes, and More–by 80 Percent
- Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
- Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus
- Diseases of Civilization–cancer, diabetes, Obesity and Acne–the Implication of Milk, IGF-1 and mTORC1
- Diseases of malfunction of body mechanisms.(Heart disease, diabetes, cancer etc.) risk by occupation, and correlation, male and female, with vehicle travel
- Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods
- Dissecting mechanisms involved in the aetiological overlap between Type 2 diabetes and cancer
- Distances over Incomplete diabetes and Breast cancer Data Based on Bhattacharyya Distance
- Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer
- DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer.
- Do colorectal cancer resections improve diabetes in long-term survivors? A case–control study
- Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A …
- Do variants associated with susceptibility to pancreatic cancer and type 2 diabetes reciprocally affect risk?
- Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
- Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?
- Does A1c predict surgical complications? A retrospective chart review of patients with Type II diabetes Mellitus and Endometrial cancer
- Does Aspirin Decrease Risk of Specific Breast cancer Subtype in Women with diabetes?
- Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?
- Does body mass index and adult height influence cancer incidence among Chinese living with incident type 2 diabetes?
- Does body mass index and adult height influence cancer incidence among people living with incident type 2 diabetes
- Does cancer risk increase with HbA 1c, independent of diabetes?
- Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort …
- Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
- Does diabetes affect [18 F] FDG standardised uptake values in lung cancer?
- Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?
- Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study …
- Does diabetes mellitus as a comorbid condition affect the health‐related quality of life in prostate cancer survivors? Results of a population‐based observational study
- Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
- Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
- Does diabetes mellitus influence standardized uptake values of fluorodeoxyglucose positron emission tomography in colorectal cancer?
- Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
- Does diabetes mellitus influence the prognosis of patients with lung cancer?
- Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
- Does diabetes mellitus play an independent prognostic role in kidney cancer?
- Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study
- Does diabetes really impact on postoperative survival in patients with colorectal cancer?
- Does diabetes therapy influence the risk of cancer?
- Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama
- Does Hyperinsulinemia in Type-II diabetes Mellitus Influence Disease Presentation and Long-Term Treatment Outcomes of Localized Prostate cancer?
- Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
- Does Metformin Protect the Bone Marrow of Patients with diabetes Treated with 131I for
Thyroid cancer?
- Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
- Does the hospitalization after a cancer diagnosis modify adherence to process indicators of diabetes care quality?
- Does the use of incretin‐based medications increase the risk of cancer in patients with type‐2 diabetes mellitus?
- Does Type 2 diabetes increase the risk of developing cancer?
- Does use of metformin protect against cancer in Type 2 diabetes mellitus?
- Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six‐year population‐based cohort study
- Dose-dependent relationship between metformin and colorectal cancer occurrence among patients with Type 2 diabetes—A nationwide cohort study
- Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients
- DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate …
- Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breast cancer being treated for hypertension and diabetes
- Drug–subphenotype interactions for cancer in type 2 diabetes mellitus
- Drugs, diabetes and cancer
- Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women’s Health Study (IWHS) cohort
- Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer
- Early Life: Epigenetic Effects on Obesity, diabetes, and cancer
- Editorial (Thematic Issue: Nutrition And Immunology In diabetes, cancer and Infectious Diseases)
- Effect of aspirin on cancer chemoprevention in Japanese patients with type 2 diabetes: 10-year observational follow-up of a randomized controlled trial
- Effect of Billroth Ⅱ Gastrectomy on Type 2 diabetes Mellitus in Patients with Gastric cancer
- Effect of blood glucose level on the prognosis of breast cancer patients with type 2 diabetes mellitus
- Effect of diabetes and Obesity on Disparities in Prostate cancer Outcomes
- Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
- Effect of diabetes Mellitus and Glycemic Control on the Prognosis of Non-muscle Invasive Bladder cancer: A Retrospective Study
- Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL
- Effect of diabetes mellitus on outcomes of colorectal cancer
- Effect of diabetes Mellitus on Patients Receiving Robotic-Assisted Laparoscopic Radical Prostatectomy for Prostate cancer
- Effect of diabetes mellitus on survival in patients with gallbladder cancer: a systematic review and meta-analysis
- Effect of diabetes Mellitus on Survival in Patients with Gallbladder cancer: A Systematic Review and Meta-analysis
- Effect of diabetes mellitus on survival in patients with pancreatic cancer: a systematic review and meta-analysis
- Effect of diabetes mellitus on the development of radiation pneumonitis in patients with non-small cell lung cancer
- Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer
- Effect of diabetes on endometrial cancer recurrence and survival
- Effect of diabetes on neurological adverse effects and chemotherapy induced peripheral neuropathy in advanced colorectal cancer patients treated with different …
- Effect of diabetes Treatment on Breast cancer Outcomes: A Systematic Review and Meta-analysis
- Effect of different chemotherapy combined with radiotherapy for the treatment of non small cell lung cancer complicated with type 2 diabetes
- Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: an observational population-based study
- Effect of digestive tract reconstructions after distal gastrectomy on gastric cancer patients complicated with diabetes
- Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study
- Effect of glitazones on cancer mortality in type 2 diabetes
- Effect of human insulin on breast cancer risk in Taiwanese women with type 2 diabetes.
- Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: a meta-analysis
- Effect of hypoglycemic agents on survival outcomes of patients with lung cancer and diabetes mellitus: A systematic review and meta-analysis.
- Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
- Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
- Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies
- Effect of multimodal information delivery for diabetes care on colorectal cancer screening uptake among individuals with type 2 diabetes
- Effect of nursing intervention on patients with breast cancer accompanied by diabetes during the perioperative period
- Effect of Nuts on Markers of cancer and Coronary Heart Disease Risk in Type 2 diabetes: A Dose Response Study
- Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
- Effect of perioperative nursing on blood sugar and complication of patients with gastric cancer complicated with diabetes mellitus
- Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives
- Effect Of Secoisolariciresinol Diglucoside (Sdg) On Colon cancer Associated With diabetes Mellitus.
- Effect of Three Procedures of Digestive Tract Reconstructions after Distal Gastrectomy on Blood Sugar of Gastric cancer Patients Complicated with diabetes
- Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer
- Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer
- Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk
- Effect of uncontrolled diabetes on outcomes after cystectomy in patients with bladder cancer: a population-based study
- Effect of yoga on chemo-radiotherapy induced diabetes and hypertension (CRID-H) among cervical cancer patients at a regional cancer institute in south India
- Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes
- Effects of aspirin or clopidogrel on colorectal cancer chemoprevention in patients with type 2 diabetes mellitus
- Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
- Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
- Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program)
- Effects of continuing nursing care on postoperative quality of life and blood glucose control in patients with bladder cancer and diabetes mellitus
- Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients
- Effects of diabetes on Ovarian cancer: Data Analysis and Modeling Study
- Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6‐year follow‐up study
- Effects of metformin on breast cancer risk and mortality in patients with type 2 diabetes
- Effects of Metformin on Breast cancer Risk and Mortality in Type 2 diabetes Mellitus: A Systematic Review and Meta-analysis
- Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
- Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis
- Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: A systematic review and meta-analysis
- Effects of Newly Diagnosed cancer on Medication Management of Prevalent diabetes
- Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type 2 diabetes mellitus and gastric cancer
- Efficacy of metformin for locally advanced rectal cancer complicating diabetes mellitus.
- Elderly diabetes and the correlation of colorectal cancer research
- Electronic nose: A non-invasive technology for breath analysis of diabetes and lung cancer patients
- Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes
- Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
- Emerging link between diabetes and cancer
- Emerging roles of cadmium and heme oxygenase in type-2 diabetes and cancer susceptibility
- Emerging trends in pancreatic cancer and diabetes.
- Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer
- Empirically supported treatments of disease-related symptoms in pediatric psychology: asthma, diabetes, and cancer.
- Enabling the nation’s schools to help prevent heart disease, stroke, cancer, COPD, diabetes, and other serious health problems
- Endocrinopathy in Pancreatic cancer Is Characterized by Reduced Islet Size and Density with Preserved Endocrine Composition as Compared to Type 2 diabetes …
- Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
- Enhanced System to Achieve Better Classification Performance in Forecasting diabetes and Breast cancer
- Enhancement of O‑linked N‑acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus
- Enhancing ensemble prediction accuracy of breast cancer survivability and diabetes diagnostic using optimized EKF-RBFN trained prototypes
- Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancer
- Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies
- Epidemiological evidence of a relationship between type‐1 diabetes mellitus and cancer: a review of the existing literature
- Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer
- Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
- Epidemiology of diabetes and cancer
- Epidemiology of diabetes and cancer: Lessons learnt
- Epigenetic mechanisms of breast cancer prevention by the Type II diabetes mellitus agent metformin
- Epithelial Mesenchymal Transition and Progression of Breast cancer Promoted by diabetes Mellitus in Mice Are Associated with Increased Expression of Glycolytic …
- Epithelial-mesenchymal transition phenotype, metformin, and survival for colorectal cancer patients with diabetes mellitus II
- Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
- Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
- Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
- Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization
- Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast cancer Health Disparities Study
- Ethno-medicinal plants for treatment of diabetes, cancer and heart diseases: Evidence based documentation from dependent stakeholders
- European Association for the Study of diabetes Annual Conference Explores Links Between diabetes and cancer
- Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method
- Evaluating the prevalence of diabetes mellitus subtypes in childhood cancer survivors: a systematic review protocol
- EVALUATING THE ROLE OF diabetes AND THE diabetes RELATED GENE, TCF2, IN PROSTATE cancer RISK AMONG AFRICAN-AMERICAN, CAUCASIAN …
- Evaluation of a mixed meal test for diagnosis and characterization of pancrEaTogEniC diabetes secondary to pancreatic cancer and chronic pancreatitis …
- Evaluation of lipid peroxidation activity at intravenous administration of gold nanorods in rats with simulated diabetes and transplanted liver cancer
- Evaluation of National Programme for Prevention and Control of cancer, diabetes, Cardiovascular disease and Stroke (NPCDCS) in Gandhinagar district, Gujarat.
- Evaluation of siRNA mediated Silencing of IKKα in Prostate cancer and CD40 in Type-1 diabetes
- Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National health insurance data in …
- Evaluation of the impact of diabetes mellitus on the biology of prostate cancer
- Evaluation the Rate of cancer Risk in Patients with diabetes: A Systematic Review
- Evidence for DNA damage as a biological link between diabetes and cancer
- Examination of cause-of-death data quality among New York City deaths due to cancer, pneumonia, or diabetes from 2010 to 2014
- Examination of the complex relationships among dietary components, type II diabetes, weight change, and breast cancer risk among Singaporean Chinese women
- Examining known diabetes risk variants for association with prostate cancer in a multiethnic population
- Examining patterns of multivariate, longitudinal symptom experiences among older adults with type 2 diabetes and cancer via cluster analysis
- Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus
- Examining the effects of metformin on survival outcome in stage II/III colorectal cancer patients with diabetes mellitus.
- Examining the Impact of First Nations Status on the Relationship Between diabetes and cancer
- Examining the multilevel influences on diabetes and hypertension clinical care management among breast cancer patients
- Examining the relationship between diabetes and prostate cancer through changes in screening guidelines
- Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish National diabetes Register–register-based cohort study …
- Excess body weight, diabetes and cancer: epidemiologic evidence implicating hormonal and metabolic mechanisms
- Excess risk of primary liver cancer in patients with diabetes mellitus
- Excess risk of thyroid cancer in individuals with type 1 diabetes compared to those without diabetes in Finland; nationwide study
- Excessive weight, inflammation, diabetes, and cancer: Relationships and differences by race
- Exercise and patient populations: A community-based exercise intervention on cancer and Type 2 diabetes
- Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes
- Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy
- Exosomes: Mediators and Therapeutic Targets of diabetes and Pancreatic cancer
- Expanding the therapeutic spectrum of metformin: from diabetes to cancer
- Experience on Treating Oesophagus Cardia cancer Combined with diabetes 52 Cases in Peri-operation Period
- Exploiting the cancer and diabetes metabolic connection for therapeutic purposes
- Exploratory study of impact of cancer‐related posttraumatic stress symptoms on diabetes self‐management among cancer survivors
- Exploring online support spaces: using cluster analysis to examine breast cancer, diabetes and fibromyalgia support groups
- Exploring opportunities for colorectal cancer screening and prevention in the context of diabetes self-management: an analysis of the 2010 National Health Interview …
- Exploring the association between diabetes and breast cancer morbidity: considerations for quality care improvements among Latinas
- Exploring the association between diabetes and breast cancer outcomes among Latinas.
- Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
- Exploring the complex and paradoxical relationships between Type 2 diabetes, obesity and cancer, as a framework for risk prediction models
- Exploring the impact of metformin on cancer risk in diabetes patients
- Exploring the link between diabetes and pancreatic cancer
- Exploring the therapeutic ability of fenugreek against type 2 diabetes and breast cancer employing molecular docking and molecular dynamics simulations
- Exposure to Electric and Magnetic Fields (EMF) Linked to Neuro-Endocrine Stress Syndrome: Increased Cardiovascular Disease, diabetes, & cancer
- Expression and significance of SIRT1 in breast cancer with diabetes meilitus
- Expression and significance of SIRT1 in breast cancer with diabetes mellitus
- Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus
- Expression of HIF-1α and correlation with angiogenesis in tissue of breast cancer complicated with diabetes
- Expression of long non-coding RNA H19 in colorectal cancer patients with type 2 diabetes
- Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
- Expression of protein kinase p70S6K in leukocytes of patients with cancer and diabetes mellitus
- Extracellular matrix glycation and RAGE activation. A missing piece in the puzzle of the association between diabetes and cancer
- Factors associated with cancer-and non-cancer-related deaths among Taiwanese patients with diabetes after 17 years of follow-up
- Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence
- Factors that may influence the risk of cancer in diabetes
- Familial diabetes frequency as a factor in diabetics suffering from cancer
- Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
- Family caregivers’ strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving
- Family diabetes and its consequences in cancer patients
- Family disease history and perceived risk for Type 2 diabetes, cardiovascular disease, cancer and depression
- Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer
- Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression
- Family history of diabetes and pancreatic cancer
- Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study
- Fasting Plasma Glucose Variability and Gastric cancer Risk in Individuals Without diabetes Mellitus: A Nationwide Population-Based Cohort Study
- Fasting‐Mimicking Diet and Risk Factors for Aging, diabetes, cancer and Cardiovascular Disease
- Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
- Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis
- Features immuno-genetic, clinical and morphological characteristics of breast cancer in patients with type 2 diabetes melliuts
- Fight against chronic diseases (high blood pressure, stroke, diabetes and cancer) in Pakistan; cost-effective interventions
- Financial Burden Over Time in Older Adults with cancer, Heart Disease, or diabetes
- Food patterns in relation to weight change and incidence of type 2 diabetes, coronary events and stroke in the Malmö Diet and cancer cohort
- For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes
- For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis
- Forecasting of breast cancer and diabetes using ensemble learning
- Formulation of a Multifunctional Flora Composite for the Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
- Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean
- Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean Region
- Four lifestyle factors prevent cancer, diabetes, and CVD
- Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort
- Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
- Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
- Frequency of type 2 diabetes in family and it’s changes in diabetic patients affected or not affected with cancer
- From diabetes to cancer: Glucose makes the difference
- From diabetes to cancer: New applications for targeting AMPK in the clinical setting
- From obesity to diabetes and cancer: epidemiological links and role of therapies
- Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors
- Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for diabetes and cancer Therapy
- FUMARATE METABOLISM IN cancer AND TYPE 2 diabetes
- Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk
- Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic cancer–Associated diabetes
- Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients
- Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK
- Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large retrospective population-based cohort study
- Gastrointestinal tract cancer and diabetes mellitus
- Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study
- GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets
- GDF-15 is associated with cancer incidence in patients with type 2 diabetes
- Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus
- Gene polymorphisms and their association with diabetes and hypertension in African American and Latina breast cancer patients
- Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
- Gene-and pathway-based genomics of breast cancer and type 2 diabetes in African American women
- Generation and biological characteristics of a mouse model of breast cancer that copresents with diabetes mellitus
- Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus
- Genes Associated with cancer, Schizophrenia and Type 2 diabetes in the Circassian and Chechen Populations in Jordan
- Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota
- Genes–environment interactions in obesity-and diabetes-associated pancreatic cancer: a GWAS data analysis
- Genetic Architecture of diabetes Mellitus in Long-term Survivors of Childhood cancer
- Genetic Basis Linking Variants for diabetes and Obesity with Breast cancer
- Genetic polymorphisms of diabetes‐related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast cancer …
- Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry
- Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk
- Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer
- Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes
- Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
- Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancer
- Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium
- Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic cancer Cohort Consortium and Pancreatic cancer …
- Genomic Epidemiology of Human Papillomavirus (HPV), Prostate cancer, and diabetes
- Genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer
- Gestational diabetes and risk of breast cancer in African American women
- Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel
- Gestational diabetes and risk of incident primary cancer: A large population-based cohort study in Israel.
- Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study
- Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study
- Gestational diabetes may increase risk of endometrial cancer later in life: Results of a population-based study in Washington State, 1987–2012
- Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature
- Gestational diabetes mellitus and risk of incident primary cancer: A population-based retrospective cohort study.
- Gestational diabetes mellitus and subsequent cancer risk: shared risk factors, causality or confounding?
- Gestational diabetes mellitus may be associated with increased risk of breast cancer
- Gestational diabetes, type II diabetes, and mammographic breast density in a US racially diverse population screened for breast cancer
- GI hormonal changes in diabetes influence pancreatic cancer growth
- Glargine safety, diabetes and cancer
- Global and regional effects of bladder cancer risk associated with pioglitazone therapy in patients with diabetes
- GLP-1 based therapy for diabetes and potential of thyroid cancer
- GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
- GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
- Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells.
- Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice …
- Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus
- Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes
- Glucose transporters: their abnormalities and significance in type 2 diabetes and cancer
- Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
- Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
- Glucose-Regulated TET2 Activity Links cancer to diabetes
- Glucose‐lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all‐cause mortality, cardiovascular events and cancer
- Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis
- Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of cancer and Nutrition (EPIC-Norfolk)
- Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into cancer (EPIC)–Norfolk prospective …
- Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography
- Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study
- Glycemia control using A1C level in terminal cancer patients with preexisting type 2 diabetes
- Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes.
- Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer
- Glycemic equilibrium of cancer patients with diabetes
- Glycemic Status, Insulin Resistance, and Risk of Pancreatic cancer Mortality in Individuals With and Without diabetes
- Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
- GO-25: Dose diabetes medication reduce recurrence of endometrial cancer?
- Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?
- Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer
- Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus
- Greater development of 1, 2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus
- Growth defect blocks cancer and diabetes
- Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and cancer–Cardiovascular Cohort
- Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans
- GSK3 inhibitors in the therapeutic development of diabetes, cancer and neurodegeneration: past, present and future
- Guest editorial: are diabetes-related wounds and amputations worse than cancer
- GW28-e0695 High-Density Lipoprotein Cholesterol and cancer Risk Among Chinese with or without diabetes Mellitus in Kailuan Cohort
- H eterogeneity in risk of prostate cancer: AS wedish population‐based cohort study of competing risks and T ype 2 diabetes mellitus
- HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden
- HDL cholesterol and cancer risk among patients with type 2 diabetes
- HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis
- HE LINK BETWEEN diabetes, diabetes TREATMENT AND cancer
- Head and neck cancer patients: impact of diabetes mellitus on surgical outcomes
- Health literacy and behavior related to cancer and diabetes among higher secondary students
- Health professionals’ views of current treatment pathways for cancer patients with comorbid diabetes
- Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE
- Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus
- Healthy gardens/healthy lives: Navajo perceptions of growing food locally to prevent diabetes and cancer
- Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
- Heart disease risk factors, diabetes, and prostatic cancer in an adult community
- Helicobacter pylori infection and Hyperglycemia/diabetes are associated with an increased risk of gastric cancer
- Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
- Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients
- Herbal Medicines for diabetes and cancer—A Global Perspective
- High glucose and diabetes increase cancer risk
- High Norepinephrine Status Induced Growth of Colorectal cancer With Type 2 diabetes Mellitus Benefited From ADP-Ribosyltransferase 1
- High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey
- High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: a hospital based study of 4610 patients with benign tumors or …
- High processed meat consumption is a risk factor of type 2 diabetes in the Alpha-Tocopherol, Beta-Carotene cancer Prevention study
- High rates of endometrial cancer among Pacific women in New Zealand: the role of diabetes, physical inactivity, and obesity
- High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 …
- High‐density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells
- Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes–The Adiponectin Paradox
- Higher Concentrations of Glucose or Insulin Increase the Risk of Various Types of cancer in Obesity or Type 2 diabetes by Decreasing the Expression of …
- Higher expression of proteins in IGF/IR axes in colorectal cancer is associated with type 2 diabetes mellitus
- Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes
- Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes
- Higher Prevalence of Prostate cancer among Veterans with Type 2 diabetes
- Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation
- Higher risk of mortality from lung cancer in Taiwanese people with diabetes
- Higher whole-grain intake is associated with lower risk of type 2 diabetes among middle-aged men and women: the Danish diet, cancer, and health cohort
- Hijacking of endocrine and metabolic regulation in cancer and diabetes
- Hijacking of Endocrine and Metabolic Regulation in cancer and diabetes
- Hints that Glitazones, diabetes Drugs, May Work Against Breast cancer
- Histone deactylase inhibitors as novel target for cancer, diabetes, and inflammation
- History of cancer and the use of ACE inhibitors: results from the Vermont diabetes information system.
- History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium
- History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.
- History of diabetes mellitus and risk of breast cancer in asian women: A meta-epidemiological analysis of population-based cohort studies
- History of diabetes mellitus and risk of prostate cancer in physicians
- History of diabetes Mellitus and Risk of Prostate cancer: A Meta-Epidemiological Study of Population-Based Cohort Studies in East Asian Men
- History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study
- History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
- History of diabetes mellitus as a risk factor for pancreatic cancer: The Iowa Women’s Health study
- History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE TM (United States)
- History of gestational diabetes mellitus and risk of incident invasive breast cancer among parous women in the Nurses’ Health Study II prospective cohort
- History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium
- History of lower-limb complications and risk of cancer death in people with type 2 diabetes
- History of treated hypertension and diabetes mellitus and risk of renal cell cancer
- HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
- Homeostasis, diabetes and cancer
- Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women
- Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
- Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
- Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
- How do people interpret their family histories of diabetes, coronary disease, or cancer?
- How does diabetes Mellitus Influence Early Postoperative Results and Survival in Rectal cancer?
- How shift work and a destabilized circadian system may increase risk for development of cancer and type 2 diabetes
- Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research
- Human insulin to increase breast cancer risk in Taiwanese women with type 2 diabetes.
- Hybrid feature selection based weighted least squares twin support vector machine approach for diagnosing breast cancer, hepatitis, and diabetes
- Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes
- Hyperglycemia among hospitalized cancer patients with co-existing diabetes mellitus.
- Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast cancer Patients without diabetes
- Hyperglycemia, classified with multiple biomarkers simultaneously in men without diabetes, and risk of fatal prostate cancer
- Hyperinsulinemia and type 2 diabetes: impact on cancer
- Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors
- Hypertension, diabetes, cognitive impairment, renal cancer, polymyalgia rheumatica and chronic hemodialysis treatment: so many diseases or just only one?
- Hypophysial disorder in mammary cancer and its relation to diabetes insipidus
- IDDF2019-ABS-0075 Serum metabonomic analysis and establishment of diagnostic model of pancreatic cancer associated diabetes
- IDDF2020-ABS-0051 Association between type-2 diabetes mellitus and platelet distribution width in patients with primary liver cancer
- Identification of key candidate genes and pathways for relationship between ovarian cancer and diabetes mellitus using bioinformatical analysis
- Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics
- Identification of Therapeutic Targets in diabetes induced Breast cancer Metastasis
- Identifying clinical factors associated with an increased risk of diabetes Mellitus among cancer survivors.
- Illuminating the diabetes–cancer link
- Immunologic predictors of diabetes mellitus in menopausal breast cancer patients
- Immunomodulatory perspectives of potential biological spices with special reference to cancer and diabetes
- Impact of cancer on adherence to glucose lowering drugs in individuals with diabetes
- Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
- Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms
- Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F
- Impact of cancer related stress on illness beliefs and glycemic control in breast cancer survivors with comorbid diabetes.
- Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting
- Impact of consumption of animal products on cardiovascular disease, diabetes, and cancer in developed countries
- Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus
- Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy
- Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
- Impact of diabetes and hyperglycemia on outcomes in advanced breast cancer patients.
- Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients
- Impact of diabetes and Hyperglycemia on Survival in Advanced Breast cancer Patients
- Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704
- Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
- Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two …
- Impact of diabetes Complications on Breast cancer Screening, Diagnosis, and Prognosis among Elderly Women with Pre-existing diabetes Using the SEER …
- Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk
- Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the cancer Prevention Study-II Nutrition Cohort
- Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study
- Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis
- Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer
- Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.
- Impact of diabetes mellitus on clinicopathological factors and relation with radiation pneumonitis in 332 patients with lung cancer
- Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer
- Impact of diabetes mellitus on complications of chemotherapy and outcomes in older patients with breast cancer
- Impact of diabetes mellitus on epithelial ovarian cancer survival
- impact of diabetes Mellitus on Head and neck cancer patients Undergoing concurrent chemoradiotherapy
- Impact of diabetes Mellitus on Head and Neck cancer Patients Undergoing Concurrent Chemoradiotherapy
- Impact of diabetes mellitus on head and neck cancer patients undergoing surgery
- Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer
- Impact of diabetes mellitus on outcomes in patients with colon cancer
- Impact of diabetes Mellitus on Outcomes in Patients With Stage II and III Colon cancer
- Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study
- Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)‐core prostate biopsy
- Impact of diabetes mellitus on the outcome of colon cancer
- Impact of diabetes mellitus on the outcome of pancreatic cancer
- Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
- Impact of diabetes Mellitus on the Treatment Outcomes of Chemotherapy in Women with Breast cancer—A Population-Based Prospective Cohort Study
- Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer
- Impact of diabetes on cancer chemotherapy outcome: A retrospective analysis.
- Impact of diabetes on clinicopathologic and genetic features of colorectal cancer formation.
- Impact of diabetes on Colorectal cancer Outcomes
- Impact of diabetes on Colorectal cancer Screening Rates in US Adults
- Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
- Impact of diabetes on early complications after pancreaticoduodenectomy in patients with pancreatic cancer
- Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
- Impact of diabetes on outcome and toxicity of neoadjuvant (chemo) radiation for rectal cancer
- Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients
- Impact of diabetes on postoperative outcomes following colon cancer surgery
- Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy
- Impact of diabetes on site-specific oncologic outcome in stage I-III colorectal cancer.
- Impact of diabetes on the outcomes of patients with castration-resistant prostate cancer treated with docetaxel: a pooled analysis of three phase III studies
- Impact of diabetes status and medication on presentation, treatment, and outcome of stage II colon cancer patients
- Impact of diabetes Status on Long Term Oncological Outcome of Stage II Colorectal cancer
- Impact of diabetes type II and chronic inflammation on pancreatic cancer
- Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer …
- Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladder cancer in patients with diabetes mellitus
- Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
- Impact of Gonadotropin-releasing Hormone Agonist on Cardiovascular Disease and diabetes Mellitus in Prostate cancer Patients: A Nationwide Population-based …
- Impact of improvement of diabetes on survival after radical pancreatic resection in patients with pancreatic cancer and diabetes
- Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
- Impact of metformin on survival in patients with type II diabetes and metastatic colorectal cancer.
- Impact of Metformin Use on Survival in Patients with Gastric cancer and diabetes Mellitus Following Gastrectomy
- Impact of obesity during adulthood on chronic disease: diabetes, hypertension, metabolic syndrome, cardiovascular disease, and cancer.
- Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study
- Impact of socio‐economic status on breast cancer screening in women with diabetes: a population‐based study
- Impact of stress on diabetes self-management in cancer survivors.
- Impact of the duration of diabetes mellitus (DM) on the outcomes of metastatic pancreatic cancer (mPC) treated with gemcitabine (G): A retrospective study
- Impact of the duration of diabetes mellitus on the outcome of metastatic pancreatic cancer treated with gemcitabine: a retrospective study
- Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
- Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
- Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a …
- Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China
- Impact on different type of gastrectomy reconstruction in patients with gastric cancer and diabetes
- Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
- Impacts of New-Onset and Longstanding diabetes on the Incidence and Mortality of Pancreatic cancer: Population Based Big-Cohort Study.
- Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
- Implications of breast cancer with diabetes mellitus on patient outcomes and care
- Implications of pancreatic cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
- Implications of prostate cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
- Implications of the hyperinsulinaemia-diabetes–cancer link for preventive efforts.
- Implications of type1/2 diabetes mellitus in breast cancer development: a general female population-based cohort study
- Importance of diabetes in inhibition of pancreatic cancer by streptozotocin
- Importance of glycemic control in cancer patients with diabetes: treatment through end of life
- Improve the performance of cancer and diabetes detection using novel technique of machine learning
- Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent …
- Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib
- Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy
- Improving Coordination of Care Among Healthcare Professionals and Patients With diabetes and cancer.
- Improving health engagement and lifestyle management for breast cancer survivors with diabetes
- Improving lifestyle behaviors after breast cancer treatment among African American women with and without diabetes: Role of health care professionals
- Improving Māori access to cancer, diabetes and cardiovascular health care: Key informant interviews
- Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical …
- Improving prediction accuracy of breast cancer survivability and diabetes diagnosis via RBF networks trained with EKF models
- In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection)
- Incidence and mortality risks of cancer in patients with type 2 diabetes: a retrospective study in Shanghai, China
- Incidence and peculiarities of thyroid cancer in patients with type 2 diabetes mellitus
- Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle diabetes Study
- Incidence and Predictors of diabetes Mellitus after a Diagnosis of Early-Stage Breast cancer in the Elderly Using Real-World Data
- Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
- Incidence of bladder cancer in type 2 diabetes mellitus patients: A population-based cohort study
- Incidence of breast cancer in women with type 2 diabetes
- Incidence of cancer in a population-based cohort of patients with type 2 diabetes
- Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients
- Incidence of diabetes after cancer development: a Korean national cohort study
- Incidence of diabetes among patients with colorectal cancer.
- Incidence of diabetes among postmenopausal breast cancer survivors
- Incidence of diabetes and its predictive factors in cancer patients treated with phosphatidylinositol 3 kinase inhibitors
- Incidence of diabetes in colorectal cancer survivors
- Incidence of diabetes mellitus, cardiovascular diseases, and cancer in patients undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) …
- Incidence of human papillomavirus‐related anogenital precancer and cancer in women with diabetes: A nationwide registry‐based cohort study
- Incidence of medication-treated depression and anxiety associated with long-term cancer, cardiovascular disease, diabetes and osteoarthritis in community …
- Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients
- Incidence of Pancreatic cancer Associated Insulin Dependent diabetes at an Inner City Hospital
- Incidence of type 2 diabetes among oral cancer patients in Hungary
- Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the European Prospective Investigation of cancer–Norfolk cohort: implications for preventive …
- Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment
- Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
- Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts
- Increased 30-day Mortality in Patients with diabetes Mellitus Undergoing Surgery for Colorectal cancer
- Increased 30-Day Mortality Risk in Patients With diabetes Mellitus After Colon cancer Surgery: A Mediation Analysis
- Increased 30‐day mortality in patients with diabetes undergoing surgery for colorectal cancer
- Increased cancer incidence around the time of type 2 diabetes diagnosis (ZODIAC-49)
- Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
- Increased cancer mortality in type 2 diabetes (ZODIAC-3)
- Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
- Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider
- Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate cancer Tissues of Men with Type 2 diabetes
- Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania
- Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
- Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
- Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
- Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis
- Increased risk of cancer death with type 2 diabetes, finds Asian study
- Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China
- Increased risk of colon cancer in men in the pre-diabetes phase
- Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality
- Increased risk of kidney cancer in a cohort of Lithuanian diabetes mellitus patients
- Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer
- Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
- Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
- Increased serum levels of betatrophin in pancreatic cancer-associated diabetes
- Increased survival in lung cancer patients with diabetes mellitus: A large cohort study
- Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer
- Incretin-based drugs and the incidence of colorectal cancer in patients with type 2 diabetes
- Incretin-based therapy and risk of pancreatic cancer in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
- Incretin-Based Therapy and Risk of Pancreatic cancer in Patients with Type 2 diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.: 20
- Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes
- Incretin‐based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
- Incretins and cancer of the bile duct in type 2 diabetes
- Incretins, diabetes, pancreatitis and pancreatic cancer: what the GI specialist needs to know
- Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based …
- Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
- Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast cancer in Elderly Women with diabetes Mellitus
- Individuals with diabetes Have an Increased Risk of Colon cancer: A Cross-Sectional Analysis: 1073
- Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer
- Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case–control study in patients with Type 2 diabetes mellitus
- Infectious and allergic diseases, cancer, and diabetes
- Infectious tenosynovitis of the long head of the biceps caused by methicillin-resistant Staphylococcus aureus in a patient with diabetes and small cell lung cancer
- Inflammation in Colorectal cancer Inflammatory Bowel Disease, and diabetes Mellitus: The Link
- Inflammation, Type 2 diabetes, and cancer: Identifying Biomarkers Associated with Colorectal cancer and Type 2 diabetes, and the Use of microRNA Molecules as a …
- Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
- Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)
- Influence of age on incident diabetes (DM) and cardiovascular disease (CVD) among prostate cancer survivors receiving androgen deprivation therapy (ADT).
- Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy
- Influence of alimentary tract reconstruction on gastric cancer patients complicated with type 2 diabetes mellitus (a report of 67 cases)
- Influence of Breast cancer and Metastases on Incidence of diabetes
- Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer.
- Influence of diabetes Melitus, BMI, and HBA1C in High Grade Prostate cancer
- Influence of diabetes mellitus and nodal distribution in endometrial cancer and correlation to clinico-pathological prognostic factors.
- Influence of diabetes mellitus on changes in plasma osmotic pressure during bowel preparation in patients undergoing radical resection for colon cancer
- Influence of diabetes mellitus on mortality in breast cancer patients
- Influence of diabetes mellitus type 2 and prolonged estrogen exposure on risk of breast cancer among women in Armenia
- Influence of diabetes on susceptibility to experimental pancreatic cancer
- Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer
- Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study
- INFLUENCE OF DIFFERENT GASTROINTESTINAL RECONSTRUCTIONS ON TYPE Ⅱ diabetes IN PATIENTS WITH DISTAL GASTRIC cancer
- Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m2
- Influence of Hypertension and diabetes on Postoperative Outcomes In cancer Patients Undergoing Moderate/High Risk Surgical Procedures
- Influence of Hypertension on the Survival of Non-Small Cell Lung cancer Patients with Type 2 diabetes Mellitus
- Influence of insulin therapy for type 2 diabetes mellitus on cancer incidence.
- Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
- Influence of pathogenetic factors of type 2 diabetes on activation of PI3K/AkT/mTOR pathway and on the development of endometrial and breast cancer
- Influence of Preexisting diabetes on Survival After a Breast cancer Diagnosis in First Nations Women in Ontario, Canada
- Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients
- INFLUENCE OF TYPE Ⅱ diabetes ON SHORT-TERM SURGICAL OUTCOMES OF PATIENTS WITH GASTRIC cancer
- Influence on blood sugar and nutrition indicators from EN or TPN for postoperative patients with gastric cancer and diabetes [J]
- Influences from the treatment of thyroid disease and diabetes mellitus on breast cancer prognosis
- Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
- Innovative approaches in oral, inhalational, and transdermal drug delivery for cancer and diabetes treatment.
- Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of β-catenin signaling
- Insights into the relationships between diabetes, prediabetes, and cancer
- Insulin glargine and cancer risk in patients with diabetes: a meta-analysis
- INSULIN RESISTANCE IN PATIENTS WITH PANCREATIC AND COLORECTAL cancer DIAGNOSED AGAINST THE BACKGROUND OF TYPE 2 diabetes …
- Insulin Resistance Is a Common Core Tethered to diabetes and Pancreatic cancer Risk
- Insulin Resistance, Metabolic Syndrome and diabetes in Women at High Risk for Breast cancer
- Insulin therapy and cancer in type 2 diabetes
- Insulin therapy and cancer risk in diabetes mellitus
- Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
- Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
- Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta‐analysis of observational studies
- Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis
- Insulin therapy in diabetes and cancer risk: current understanding and implications for future study
- Insulin therapy, duration of diabetes linked to cancer risk
- Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies
- Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes
- Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
- Insulin-increasing diabetes therapies raise risk of death from cancer
- Insulin-like growth factor genetic variation, colorectal cancer and diabetes
- Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer
- Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes
- Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes
- Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
- Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries
- Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition-Netherlands cohort …
- Intensive glucose control and risk of cancer in patients with type 2 diabetes
- Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
- Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial
- Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial
- Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients
- Interactions between diabetes and cancer
- Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer
- Interim Report-September 2011 Cohort Study of Pioglitazone and cancer Incidence in Patients with diabetes Mellitus Extended Follow-up (1997-2009)
- Interrelationship between oxidative stress, DNA damage and cancer risk in diabetes (Type 2) in Riyadh, KSA
- Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis
- Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
- Investigating the Mechanisms Underlying the Link Between diabetes and cancer
- Investigation of the biological function of fibroblast activation protein and its potential as a therapeutic target in cancer and diabetes
- Investigation of the presence of polymorphism in exons 2 and 3 of the DIRAS3 gene in women with breast cancer and diabetes
- Involvement of Adrenomedullin Expression in Tumor Cells and Stroma in the Development of diabetes in Pancreatic cancer Patients
- Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer
- Is cancer incidence different between type 2 diabetes patients compared to non-diabetics in hemodialysis? A study from the REIN registry
- Is colorectal cancer associated with diabetes mellitus?
- Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms
- Is diabetes a risk factor for colorectal cancer?
- Is diabetes Associated with Progression to Dysplasia or cancer in Barrett’s Esophagus?: 49
- Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?
- Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
- Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer?
- Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
- Is diabetes mellitus a risk factor for pancreatic cancer?
- Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?
- Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort …
- Is diabetes mellitus associated with poorly differentiated prostate cancer (PCA)?
- Is diabetes mellitus associated with prostate cancer incidence and survival?
- Is there a link between BRCA1 and BRCA2 mutations and obesity, high blood pressure and diabetes mellitus in Romanian high-risk breast cancer cases?
- Is there any relation between diabetes therapy and cancer risk?
- Is there evidence for sex differences in the association between diabetes and cancer?
- Is there evidence for sex differences in the association between diabetes and cancer? Reply to Dankner R, Boker LK, Freedman LS
- Is type 2 diabetes a risk factor for pancreatic cancer
- Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study
- Is Type 2 diabetes Mellitus a Risk Factor for Pancreatic cancer and is Metformin Able to Prevent this Risk?
- Is Type 2 diabetes Mellitus Causally Associated with cancer Risk? Evidence from a Two-Sample Mendelian Randomisation Study
- Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
- Islet hormone secretion in pancreatic cancer patients with diabetes.
- Islet inflammation: a causal link between diabetes and pancreatic cancer?
- Isoform-and Paralog-Switching in IR-Signaling: When diabetes Opens the Gates to cancer
- Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan
- Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
- Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
- Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
- Knowledge, attitudes, and practices related to pet contact by immunocompromised children with cancer and immunocompetent children with diabetes
- KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer
- Lactate, a neglected factor for diabetes and cancer interaction
- Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood …
- Late-onset diabetes and the link with pancreatic cancer
- Latest insights into the risk of cancer in diabetes
- LEISURE-TIME PHYSICAL ACTIVITY AND THE ONSET OF TYPE 2 diabetes IN THE MALMÖ DIET AND cancer STUDY COHORT
- Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
- Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: an unexpected finding?
- Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
- Letter to the Editor-The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes
- Letter to the Editor: Comments on “Use of metformin and risk of kidney cancer in patients with type 2 diabetes”, Chin‐Hsiao Tseng, Eur J cancer 2016; 52: 19 …
- Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam study
- Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer
- Linking type 2 diabetes and gynecological cancer: an introductory overview
- Links among type 2 diabetes, cancer and metformin use: What have we learned?
- Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations
- LIVER cancer PREDICTION FOR TYPE-II diabetes USING CLASSIFICATION ALGORITHM.
- Liver cirrhosis with high IgG4 in a patient with, diabetes mellitus, ulcerative colitis with papillary thyroid cancer, is it all related? which one to blame& is it time to raise …
- Liver enzymes and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
- Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes
- Long-standing diabetes and its effects on outcomes in colon cancer.
- Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
- Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a meta-analysis
- Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study
- Long-term diabetes risk among ovarian cancer survivors in a population-based cohort study
- Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort
- Long-term follow-up for type 2 diabetes mellitus after gastrectomy in non-morbidly obese patients with gastric cancer: the legitimacy of onco-metabolic surgery
- Long-term Mortality in cancer Patients With Preexisting diabetes
- Long-term Mortality in cancer Patients With Preexisting diabetes—Reply
- Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes
- Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus
- Loss of microRNA expression is involved in the development and prognosis of breast cancer complicated by Type 2 diabetes mellitus
- Low cancer death rate in chronic dialysis patients with diabetes mellitus
- Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong diabetes Registry
- Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
- Low National Breast and Cervical cancer Screening Rates in American Indian and Alaska Native Women with diabetes
- Low national breast and cervical cancer-screening rates in American Indian and Alaska Native women with diabetes
- Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmö Diet and cancer study
- Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong diabetes Registry
- Low-dose aspirin reduces breast cancer risk in women with diabetes: a nationwide retrospective cohort study in Taiwan
- Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes
- Lung cancer and diabetes: A role for advanced glycation end‐products?
- Lung cancer presenting as Central diabetes Insipidus
- Lung cancer risk, diabetes, and diabetes treatments.
- MA06. 07 Impact of Type 2 diabetes Mellitus and Its Metabolic Control on Prognosis of Unresectable Non-Small Cell Lung cancer Patients
- Machine Learning in Healthcare: Breast cancer and diabetes Cases
- Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer
- Mammary Adipose Tissue Control of Breast cancer Progression: Impact of Obesity and diabetes
- Management of colorectal cancer and diabetes
- Management of comorbid diabetes and cancer in the elderly
- Management of comorbid diabetes and cancer.
- Management of diabetes and pancreatic cancer.
- Management of diabetes in patients with cancer
- Management of diabetes mellitus in terminally ill cancer patients
- Managing diabetes in cancer patients
- Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines
- Managing people with diabetes during the cancer palliation in the era of simultaneous care
- Mandibular reconstruction using 2-step bone transport in an irradiated cancer patient with type 2 diabetes mellitus
- Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension
- Mass spectrometry in the analysis of peptides involved in cancer, diabetes and long-term memory
- Maternal diabetes and incidence of childhood cancer–a nationwide cohort study and exploratory genetic analysis
- Maternal diabetes and risk of childhood cancer in the offspring
- Maternal perceptions of paediatric cancer and diabetes in Cameroon
- Maternal pre-pregnancy and gestational diabetes, obesity, gestational weight gain, and risk of cancer in young children: a population-based study in California
- Mathematical Medicine: Modeling Disease and Treatment Key words: Immune dynamics; cancer; diabetes; Ordinary differential equations
- Matricaria Chamomile Protective Effect Against Type-2 diabetes Mellitus and cancer Cell Linings
- Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus
- Measures of impact: diabetes and urothelial cancer
- Mechanism (s) of pancreatic cancer-induced diabetes
- Mechanism of protein kinase B activation by insulin IGF1 revealed by specific inhibitors of the phosphoinositide 3-kinase. Significance for diabetes and cancer
- Mediation of black/white disparities in triple negative breast cancer by socioeconomic position, reproductive factors and diabetes in the Nurses’ Health Study Cohorts I …
- Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer
- Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition (EPIC) study: the InterAct project
- Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 diabetes and cancer
- Meta-analysis of androgen deprivation therapy for prostate cancer related with diabetes
- Meta-analysis of mitochondrial T16189C polymorphism for cancer and Type 2 diabetes risk
- Meta-analysis of the relationship between type 2 diabetes and the risk of kidney cancer
- Meta‐analysis of the association between sodium‐glucose co‐transporter‐2 inhibitors and risk of skin cancer among patients with type 2 diabetes
- Metabolic Adaptations in diabetes Mellitus and cancer
- Metabolic reprogramming in type 2 diabetes and the development of breast cancer
- Metabolic syndrome and diabetes mellitus in childhood cancer survivors.
- Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways
- Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition-Potsdam Study
- Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer
- Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms
- Metastatic breast cancer presenting with diabetes insipidus
- Metastatic breast cancer presenting with diabetes insipidus.
- Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among US veterans.
- Metformin ameliorates testicular damage in diabetes and prostate cancer model
- Metformin and biliary tract cancer in patients with type 2 diabetes
- Metformin and breast and gynecological cancer risk among women with diabetes
- Metformin and cancer in type 2 diabetes
- Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
- Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan
- Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
- Metformin and Gastrointestinal cancer Development in Newly Diagnosed Type 2 diabetes: A Population-Based Study in Korea
- Metformin and lung cancer risk in patients with type 2 diabetes mellitus
- Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta‑analysis
- Metformin and pancreatic cancer risk in patients with type 2 diabetes
- Metformin and pancreatic cancer risk in Taiwanese patients with type 2 diabetes
- Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal cancer and diabetes in Mice
- Metformin and reduced risk of cancer in the Hong Kong diabetes registry: real effect or immortal time bias?
- Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
- Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus
- Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies
- Metformin and the incidence of cancer in patients with diabetes: a nested case-control study
- Metformin and the incidence of prostate cancer in patients with type 2 diabetes
- Metformin and the incidence of prostate cancer in patients with type 2 diabetes
- Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives
- Metformin as a risk factor of pathogenesis of colorectal cancer in type 2 diabetes patients: a Meta-analysis
- Metformin associated with increased survival in type 2 diabetes patients with pancreatic cancer and lymphoma
- Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16
- Metformin Associates With Aggressive Features of Endometrial cancer in Women With Type 2 diabetes
- Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis
- Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
- Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus
- Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes
- Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes
- Metformin effect on clinical course of non-small cell lung cancer (NSCLC) in patients (pts.) with concomitant diabetes mellitus (DM) after radical resection.
- Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis
- Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population
- Metformin for Reducing Racial/Ethnic Difference in Prostate cancer Incidence for Men with Type 2 diabetes Running title: Metformin for Reducing Prostate cancer …
- Metformin for reducing racial/ethnic difference in prostate cancer incidence for men with type II diabetes
- Metformin has a positive therapeutic effect on prostate cancer in patients with type 2 diabetes mellitus
- Metformin Impacts the Prognosis of cancer Patients with Type 2 diabetes
- Metformin improves overall survival of colorectal cancer patients with diabetes: a meta-analysis
- Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer
- Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis
- Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer
- Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
- Metformin Inhibits Thyrocyte Growth and Increases Complete Responses in Differentiated Thyroid cancer in Patients with diabetes
- Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: a retrospective cohort analysis
- Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes
- Metformin is associated with reduced odds for colorectal cancer among persons with diabetes
- Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
- Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: a meta-analysis
- Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis
- Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
- Metformin May Cut Risk of cancer in Type 2 diabetes
- Metformin may reduce bladder cancer risk in patients with type 2 diabetes
- Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
- Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes
- Metformin may reduce oral cancer risk in patients with type 2 diabetes
- Metformin Prevents cancer in Type 2 diabetes
- Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs
- Metformin protects against diabetes–induced heart injury and dunning prostate cancer model
- Metformin reduces colon cancer risk in patients with type 2 diabetes: a retrospective cohort analysis
- Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
- Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
- Metformin Reduces Radiation-Induced Cardiac Toxicity Risk in Patients Having diabetes and Breast cancer: Results from the Taiwan National Cohort and Basic …
- Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National diabetes Program Cohort
- Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes
- Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus
- Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
- Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
- Metformin therapy associated with survival benefit in lung cancer patients with diabetes
- Metformin treatment and cancer risk: Cox regression analysis, with time-dependent covariates, of 320,000 persons with incident diabetes mellitus
- Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
- Metformin use and cervical cancer risk in female patients with type 2 diabetes
- Metformin use and its effect on gastric cancer in patients with type 2 diabetes: a systematic review of observational studies
- Metformin use and kidney cancer outcomes in patients with diabetes: a propensity score analysis
- Metformin use and lung cancer risk in patients with diabetes
- Metformin use and pancreatic cancer survival among non-Hispanic White and African American US veterans with diabetes mellitus
- Metformin use and pancreatic cancer survival in US veterans with diabetes mellitus: Are there racial differences?
- Metformin use and renal cell cancer outcomes among patients with diabetes.
- Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural …
- Metformin use and risk of lung cancer in patients with diabetes.
- Metformin Use and the Incidence of Colorectal and Lung cancer in Patients with Type 2 diabetes Mellitus
- Metformin use and the risk of cancer in patients with diabetes: A nationwide sample cohort study
- Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
- Metformin Use for diabetes May Reduce cancer Risk in DM1
- Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis
- Metformin—mode of action and clinical implications for diabetes and cancer
- Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells
- Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
- Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells
- Metformin, diabetes, and survival among US veterans with colorectal cancer
- Metformin, diabetes, and Survival among US Veterans with Colorectal cancer
- Metformin, diabetes, and Survival among US Veterans with Colorectal cancer—Response
- METFORMIN, STATINS AND THE RISK AND PROGNOSIS OF ENDOMETRIAL cancer IN WOMEN WITH TYPE 2 diabetes
- Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
- Metformin: a bridge between diabetes and prostate cancer
- Metformin: a salutary candidate for colorectal cancer treatment in patients with diabetes
- Metformin: on ongoing journey across diabetes, cancer therapy and prevention
- Metformin: Possible Use of a diabetes Drug in Treatment of cancer
- Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
- Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
- Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
- MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1
- MicroRNA, diabetes Mellitus and Colorectal cancer
- MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer
- MicroRNAs 103 and 107: potential molecular links between diabetes and cancer
- Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer
- Microvascular reconstruction in elderly oral cancer patients: does diabetes status have a predictive role in free flap complications?
- Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
- Midlife cancer/diabetes and risk of dementia and mild cognitive impairment: A population-based prospective cohort study in Japan
- Milk intake and the risk of type 2 diabetes mellitus, hypertension and prostate cancer
- MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus
- miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’molecule moving as a monitor in the ‘genomic galaxy’
- Mitochondrial dynamics in type 2 diabetes and cancer
- Modalities for assessing the nutritional status in patients with diabetes and cancer
- Model Checking a Synchronous diabetes–cancer Logical Network
- Model Checking of a diabetes‐cancer Model
- Model to determine risk of pancreatic cancer in patients with new-onset diabetes
- Model to Determine Risk of Pancreatic cancer in Patients with New-onset diabetes Running title: END-PAC Risk Stratification Score
- Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer
- Modeling effects of diabetes and obesity co-morbidities in endometrial cancer development and progression
- Moderating effects of sleep duration on diabetes risk among cancer survivors: Analysis of the National Health Interview Survey in the USA
- Modern Eggs, Not Wild Type Eggs, Predispose Risk of Cardiovascular Disease, diabetes and cancer?
- Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
- Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival
- Modifications of fibronectin in age-related diseases: diabetes and cancer
- Molecular Correlations between Breast cancer and diabetes Mellitus Type 2 Examined by In Silico analyses and Drug Inhibitory Effects
- Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
- Molecular mechanisms and therapeutic effects of (−)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration
- Molecular mechanisms of metformin for diabetes and cancer treatment
- Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects
- Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2 diabetes and cancer
- Molecular targets of functional foods and bioactive compounds in the prevention of type 2 diabetes and colon cancer
- MON-008 Use of National Death Index to Assess cancer Mortality and diabetes Relationship
- MON-116 Metabolic Parameters in cancer Patients with and Without diabetes Mellitus
- MON-678 Worsening diabetes Control in Breast cancer Patients Treated with Alpelisib
- MON-LB306 Association Between cancer Related Beliefs and diabetes Medication Adherence Among Breast cancer Survivors With Comorbid Type 2 diabetes
- Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
- Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based …
- Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based on …
- Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
- Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer
- Mortality and glycemic control among patients with gastric and esophageal cancer and diabetes mellitus.
- Mortality causes in cancer patients with type 2 diabetes mellitus
- Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level
- MP-1.06: Is diabetes Mellitus Associated with Aggressive Characteristics in Prostate cancer?
- MP36-16 EFFECTS OF diabetes ON RENAL cancer PROGNOSIS
- MP37-08 THE ASSOCIATION BETWEEN diabetes AND PROSTATE cancer-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER …
- MP54-12 diabetes MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF cancer-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL …
- MP59-12 IS diabetes MELLITUS ASSOCIATED WITH cancer SPECIFIC AND OVERALL SURVIVAL IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA?
- MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDER cancer AND UNCONTROLLED diabetes: A POPULATION-BASED STUDY
- MP77-03 diabetes MELLITUS INCREASES BLADDER cancer RECURRENCE RISK IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
- MP77-14 diabetes MELLITUS, METFORMIN AND PROSTATE cancer: RESULTS OF A PROSTATE cancer DATABASE ANALYSIS
- mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
- mTOR: from growth signal integration to cancer, diabetes and ageing
- Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes
- Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
- Multivariate analysis on the effects of diabetes and related clinical parameters on cervical cancer survival probability
- Mutant p53 and HbA1c in Type 2 diabetes Melitus Patients With and Without cancer
- Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer
- Mycobacterium neoaurum Bloodstream Infection Associated with a Totally Implanted Subclavian Port in an Adult with diabetes and History of Colon cancer
- Myelotoxicity of cyclophosphamide, methotrexate and 5-fluorouracil regimen in the early stage breast cancer patients with diabetes mellitus
- Nanomedicine: cancer, diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases
- Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: cancer, diabetes, and Cardiovascular Disease
- Nanowires for early cancer and diabetes diagnosis via micro-RNA detection in urine extracellular vesicles
- NATIONAL ESTIMATES OF UTILIZATION AND EXPENDITURES FOR PATIENTS WITH diabetes AND cancer
- Nationwide trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors
- NCOA5, a molecular link between type 2 diabetes and liver cancer
- Neither hormonal factors nor AGEs explain lower prostate cancer risk in older men with diabetes mellitus
- Nephrogenic diabetes insipidus. An unusual presentation of recurrent rectal cancer
- Nerve growth factor as an important possible component of novel therapy for cancer, diabetes and cardiovascular diseases
- Neurogenic diabetes insipidus: an unusual clinical presentation of small cell lung cancer.
- Neuronatin gene: imprinted and misfolded: studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream …
- New diabetes drug: Colon cancer friend or foe?
- New insight into metformin action: diabetes, prostate cancer, ion channels
- New insights in the molecular pathways linking obesity, type 2 diabetes and cancer
- New insights into pancreatic cancer-induced paraneoplastic diabetes
- New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review
- NEW ONSET TYPE 1 diabetes AFTER DOUBLE IMMUNOTHERAPY FOR NEUROENDOCRINE LUNG cancer
- New resveratrol analogues for potential use in diabetes and cancer
- New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes
- New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study
- New-onset diabetes and pancreatic cancer
- New-onset diabetes as an early sign of pancreatic cancer
- New-Onset diabetes Confers Increased Risk for Pancreatic cancer in a Large Cohort of US Veterans: 732
- New-onset diabetes in pancreatic cancer: a study in the primary care setting
- New-onset diabetes mellitus and risk of pancreatic cancer: A systematic review and meta analysis.
- New-onset diabetes patients need pancreatic cancer screening?
- New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer
- New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population
- New-onset diabetes: a clue to the early diagnosis of pancreatic cancer
- New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
- New-onset diabetes: aclue to the early diagnosis of pancreatic cancer/Mechanism (s) of pancreatic cancer-induced diabetes
- New-Onset or Exacerbation of diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic cancer
- New-onset type 2 diabetes mellitus–a high-risk group suitable for the screening of pancreatic cancer?
- New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
- Newly Diagnosed diabetes Mellitus With Pancreatic cancer Manifested as Hyperglycemic Hyperosmolar State
- Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer
- News Briefs: Advances in Diagnosis/Treatment Options For diabetes, cancer, Incontinence, Peyronie’s Disease
- Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
- NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer
- No Association of Obesity and Type 2 diabetes Mellitus Related Genetic Variants With Colon cancer
- No association of risk variants for diabetes and obesity with breast cancer: the Multiethnic Cohort and PAGE studies
- No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE
- No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
- No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and …
- Non-coding RNAs in IGF-1R signaling regulation: the underlying pathophysiological link between diabetes and cancer
- Non-enzymatic glycation of proteins: from diabetes to cancer
- Non-enzymatic glycation of proteins: from diabetes to cancer
- Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
- Novel blood biomarkers of pancreatic cancer–associated diabetes mellitus identified by peripheral blood–based gene expression profiles
- Novel cancer therapies and their association with diabetes
- Novel strategies halt cardiovascular, diabetes, and cancer strips
- Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?
- Number of amalgam fillings in relation to cardiovascular disease, diabetes, cancer and early death in Swedish women
- Nursing evaluation on early enteral nntrition after operation inpatients of careinoma of stomach cancer complicated with diabetes [J]
- Nursing for 49 Cases of Lung cancer Complicated with diabetes Mellitus at Chemotherapy [J]
- Nursing intervention on senile rectal cancer complicated with diabetes
- Nursing on cancer patients with diabetes treated by chemotherapy regimen including taxanes agents
- Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis
- Nutrient Regulation of Transcription & Signaling by O-GlcNAc: Fundamental Roles in diabetes, Neurodegeneration and cancer
- Nutrition and triple major risk of abdominal obesity: type 2 diabetes mellitus, cardiovascular diseases and cancer.
- Nutrition Interventions and Self-Management in Patients with Comorbid cancer and diabetes: A Narrative Review
- Nutrition Update: Pancreatic cancer and diabetes
- Nutrition, diabetes, and cancer
- Nutritional care with diabetes and ENT cancer
- Nutritional fats and the risk of type 2 diabetes and cancer
- Nutritional status and survival of 8247 cancer patients with or without diabetes mellitus—results from a prospective cohort study
- Nutritional therapy of cancer with diabetes mellitus [J]
- O-GlcNAc signaling: a metabolic link between diabetes and cancer?
- Obesity and diabetes as prognostic factors in patients with colorectal cancer
- Obesity And diabetes Can Cause cancer
- Obesity and diabetes: the increased risk of cancer and cancer-related mortality
- Obesity and the risk of type 2 diabetes mellitus and certain types of cancer
- Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence
- Obesity as a factor in the development of cancer in type 2 diabetes
- Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus
- Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis
- Obesity, diabetes and Breast cancer: Defining Metabolic Oncogenesis
- Obesity, diabetes and cancer: a mechanistic perspective
- Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency
- Obesity, diabetes and the risk of colorectal adenoma and cancer
- Obesity, diabetes and the Risk of Colorectal Adenoma and cancer
- Obesity, diabetes mellitus and vascular disease: a complex relationship with prostate cancer
- Obesity, diabetes mellitus, and cancer
- Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
- Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis
- Obesity, diabetes, and risk of cancer
- Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial
- Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
- Obesity, diabetes, cancer and cardiovascular risk: a trans-generational network
- Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study
- Obesity, diabetes, the cardiorenal syndrome, and risk for cancer
- OBESITY, HYPERINSULINEMIA, IGF-1, AND HYPERGLYCEMIA AS RISK FACTORS FOR COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes …
- Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer
- Obesity, type 2 diabetes and cancer
- Obesity, Type 2 diabetes and cancer Risk
- Obesity, type 2 diabetes and risk of digestive cancer
- Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
- Obesity, Type 2 diabetes, and cancer: The Insulin and Insulin-Like Growth Factor Connection.
- Obesity, type-2 diabetes and cancer: mechanistic insights
- Obesity: Is it an Independent Risk Factor for diabetes and cancer
- Observation of application mode of insulin in perioperative colon cancer patients with diabetes mellitus
- Observation of different infusion methods of insulin in TPN in gastric cancer patients with diabetes after operation
- Occult colon cancer in a patient with diabetes and recurrent Klebsiella pneumoniae liver abscess
- Older adults with diabetes and cancer: Impact on diabetes self-management
- Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes …
- On the Correlation Between the” Corrected” cancer and diabetes Deathrates
- On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment
- Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer
- Oncogenic Function of a diabetes Target SHIP2 Presents Novel cancer Therapeutic and Preventive Opportunities
- Opioids and risk of type 2 diabetes in adults with non-cancer pain
- Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus
- Optimal glycemic target level for colon cancer patients with diabetes
- OPTIMIZING LIFESTYLE REDUCES THE RISK OF cancer IN diabetes
- Oral cancer in Taiwan: is diabetes a risk factor?
- ORAL CONDITIONS OF cancer PATIENTS ASSOCIATED WITH diabetes AND ARTERIAL HYPERTENSION: CASE REPORT
- Oral Glucose Lowering Agents and cancer in Type 2 diabetes Mellitus: Focus on Sulphonylurea Derivatives
- Oral Insulin Secretagogues and cancer Risk in Type 2 diabetes Mellitus: An Updated Review
- Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus
- Orbital Cellulitis Following Hordeolum in an Immunocompromised Patient with diabetes and Breast cancer-A Case Report
- Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN
- Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
- Our experience with pancreatic cancer and its relation to diabetes mellitus
- Outcome after curative surgery for gastric cancer patients with type 2 diabetes
- Outcome after gastrectomy in gastric cancer patients with type 2 diabetes
- Outcome effectiveness of therapeutic recreation camping program for adolescents living with cancer and diabetes
- Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer
- Ovarian cancer Increases the Risk of Stroke, but Not in Patients with Hypertension, diabetes or Both
- Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts
- Overall Survival Found Worse in Study of Prostate cancer Patients with diabetes, but Applicability for Now Probably Limited
- Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle
- Oxidative Stress and its Clinical Consequences: Relationship between diabetes and cancer
- Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer
- P-238 Metformin reduces biliary tract cancer in patients with type 2 diabetes
- P-268 diabetes and risk of pancreatic cancer
- P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up
- P0194 Association between abdominal obesity and type 2 diabetes and HSP70-2 (+ 1267) gene mutation in colorectal cancer
- P0293 PANDORA’S BOX–diabetes INSIPIDUS UNVEILS METASTATIC cancer
- P1-08-06: Breast cancer among Patients with diabetes, Obesity and Abnormal Blood Lipids–A Population-Based Register Study in Sweden.
- P5496 Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review …
- Painful neuropathy in a diabetic patient resulting from lung cancer and not diabetes: A case report
- Pan-PPAR Agonists as Potential Treatments for Type 2 diabetes, and the Effect of Adipocyte-derived Fatty Acids in Breast cancer Therapy
- Pancreatic cancer and diabetes
- Pancreatic cancer and diabetes
- Pancreatic cancer and diabetes
- Pancreatic cancer and diabetes mellitus
- Pancreatic cancer and diabetes mellitus
- Pancreatic cancer and diabetes mellitus
- Pancreatic cancer and diabetes mellitus: A retrospective cohort study.
- Pancreatic cancer and diabetes: a two-way relationship in the perspective of diabetologist
- Pancreatic cancer and diabetes: Is diabetes a risk factor or the outcome?
- Pancreatic cancer and diabetes: is there a relationship? A case‐controlled study
- Pancreatic cancer and its Relationship to New-onset Type 2 diabetes Mellitus
- Pancreatic cancer and sugar diabetes
- Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
- Pancreatic cancer following incident diabetes in African Americans and Latinos: the multiethnic cohort
- Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
- Pancreatic cancer manifesting as Sister Mary Joseph nodule during follow up of a patient with type 2 diabetes mellitus: A case report
- Pancreatic cancer presenting as new-onset diabetes
- Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
- Pancreatic cancer–association with diabetes mellitus and smoking
- Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications
- Pancreatic cancer-Associated diabetes: Is a Nihilistic Approach Justifiable
- Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?
- Pancreatic cancer-induced diabetes: a call to action
- Pancreatic cancer–associated diabetes is an “exosomopathy”
- Pancreatic cancer–Associated diabetes is Clinically Distinguishable From Conventional diabetes
- Pancreatic cancer–associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
- Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
- Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes
- Pancreatic cancer: The importance of screening in atypical diabetes presentations.
- Pancreatic expression of immunoglobulin G in human pancreatic cancer and associated diabetes
- Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus
- Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized …
- Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop
- Pancreatitis, pancreatic cancer, and diabetes
- Partial cranial diabetes insipidus in breast cancer: invisible pituitary metastases or uncanny coincidence
- Pathogenegenetic mechanisms of oncogenesis in diabetes mel litus and analysis of cancer incidence in patients w ith diabetes mellitus in the Precarpathian region
- Pathogenesis of Pancreatic cancer-Related diabetes Mellitus: Quo Vadis?
- Pathogenic bacteria distribution and drug resistance of postoperative infection in elderly patients with gastric cancer complicated with diabetes mellitus
- Pathologic and molecular characteristics of colorectal cancer in patients with type 2 diabetes
- Pathophysiological link between diabetes and colorectal cancer: effect of diabetic microenvironment, metformin and 5-fluorouracil on AMPK activation, apoptosis and …
- Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study
- Patient-centered prevention strategies for cardiovascular disease, cancer and diabetes
- Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer
- Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study
- Pay more attention to the study of the relationship between diabetes mellitus and cancer
- PCN173 EFFECT OF METFORMIN ON SURVIVAL AMONG OVARIAN cancer PATIENTS WITH COMORBID diabetes: A SYSTEMATIC REVIEW AND …
- PD12-4: THE IMPACT OF diabetes MELLITUS ON PATIENTS RECEIVING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR PROSTATE cancer
- PD13-09 diabetes SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE …
- PD19-02 diabetes MELLITUS AND PROSTATE cancer RISK IN A SINGLE INSTITUTIONAL BIOPSY SERIES
- PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
- Peer Reviewed: A diabetes Pay-for-Performance Program and Risks of cancer Incidence and Death in Patients With Type 2 diabetes in Taiwan
- Peer Reviewed: Associations Between Colorectal cancer Screening and Glycemic Control in People With diabetes, Boston, Massachusetts, 2005-2010
- Peer reviewed: diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system
- Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer
- Perceived Determinants of cancer Screenings in Women with diabetes
- Perceived experiences of discrimination in health care: a barrier for cancer screening among American Indian women with type 2 diabetes
- Perceived impact of cancer treatment on diabetes self-management
- Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center
- Perceived medical discrimination in American Indian women: Effect on health care decisions, cancer screening, diabetes services and diabetes management
- Performance analysis of Machine learning classifiers for predicting diabetes and prostate cancer
- Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
- Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease—is there cause for …
- PERIOPERATIONAL MANAGEMENT OF CARDIAC cancer & ITS CONCOMITANT diabetes MELLITUS
- Perioperative Management for Patients with Esophageal and Cardiac cancer Complicated with diabetes Mellitus [J]
- Perioperative Management of 288 Cases with Esophageal cancer or Cardiac cancer Complicated with diabetes Mellitus
- Perioperative management of colonrectal cancer patients with diabetes mellitus
- Perioperative management of esophageal cancer patients concomitent with diabetes
- Perioperative management of esophageal cancer patients concomitent with diabetes [J]
- Perioperative management of gastric cancer with diabetes [J]
- Perioperative management of large bowel cancer patients with diabetes mellitus
- Perioperative management of patients of colonorectal cancer with diabetes mellitus
- Perioperative Nursing for the Patients with Breast cancer Combined with diabetes Mellitus [J]
- Perioperative nursing in patients with rental cancer complicated with diabetes [J]
- Perioperative nursing of cervical cancer patients with diabetes mellitus
- Perioperative nutrition support for esophageal cancer complicated with diabetes mellitus
- Perioperative Treatment of Gastrointestinal cancer Combined with diabetes
- Perioperative treatment of patients with colorectal cancer and diabetes [J]
- Perioperative treatment of patients with gastric cancer complicated with diabetes
- Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
- Peroxisome proliferator-activated receptor gamma (PPARγ) as a target for concurrent management of diabetes and obesity-related cancer
- Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study
- Personalized diabetes and cancer medicine: A rationale for anti-diabetic nutrition (bitter melon) in a supportive setting
- Personalized indicator thrombocytosis shows connection to staging and indicates shorter survival in colorectal cancer patients with or without type 2 diabetes
- Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases
- Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies
- Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer
- Pharmacotherapy of diabetes and cancer risk
- Phosphate diabetes associated with bone metastases of oat cell lung cancer.
- Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
- Phosphorylation of Protein Kinase Akt by Mtorc2 in Peripheral Blood Mononuclear Cells of Patients with cancer and diabetes.
- Physical activity and mental distress among Veteran cancer survivors with heart disease and diabetes
- Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response …
- Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis
- Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies
- Picture quiz: diabetes insipidus in a woman with breast cancer
- Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
- Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes
- Pioglitazone and oral cancer risk in patients with type 2 diabetes
- Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world …
- Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2
- Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes
- Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
- Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis
- Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes
- Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
- Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
- Pituitary metastasis from breast cancer presenting as diabetes insipidus
- Pituitary metastasis: lung cancer presenting as bitemporal hemianopsia with diabetes insipidus and anterior pituitary deficiency
- Pituitary stalk metastasis from lung cancer, preceding diabetes insipidus–case report and clinical review of the literature
- Plasma adropin as a potential marker predicting obesity and obesity-associated cancer in Korean patients with type 2 diabetes mellitus
- Plasma Lipidome and Prediction of Type 2 diabetes in the Population-Based Malmö Diet and cancer Cohort
- Plasma metals and cancer incidence in patients with type 2 diabetes
- Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality
- Plasma-free amino acid profiles are predictors of cancer and diabetes development
- Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer
- Platelet Hyperactivity and Dysfunction in diabetes and cancer
- Pleiotropic effects of single nucleotide polymorphophisms of EDIL3 gene: Association with cancer, obesity, and type 2 diabetes
- Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer
- Pneumonia, diabetes and prostate cancer
- PO-240 WWOX suppressor gene regulate glucose metabolism and warburg effect in case of gestational diabetes mellitusas well as breast cancer
- POD-11.08: diabetes and risk of death from cancer of the prostate, kidney, and urinary bladder
- Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study
- Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus
- Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population
- Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the …
- Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states
- Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
- Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
- Population‐based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women
- POS-03.118: Influence of diabetes mellitus on the prognosis of prostate cancer patients
- Positive association between diabetes mellitus and risk of colorectal cancer.
- Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: National cohort study
- Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
- Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
- Poster# 0598–Type 2 diabetes Mellitus-A risk indicator for colorectal cancer
- Postmenopausal women with diabetes risk breast cancer
- Postmenopausal women with medically treated diabetes have increased risk of lung cancer
- Postoperative diabetes mellitus following resection of the body and tail of the pancreas for secondary invasion by gastric cancer
- Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis
- Postoperative serum carcinoembryonic antigen levels cannot predict survival in colorectal cancer patients with type II diabetes
- Postpancreatitis diabetes confers higher risk for pancreatic cancer than type 2 diabetes: Results from a nationwide cancer registry
- Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer
- PP28 Exploring the Associations between diabetes and Site-Specific cancer Mortality: Evidence from the Health Survey for England and Scottish Health Survey linked …
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
- PPAR-γ: A multifaceted transcription factor important in diabetes, cardiovascular disease, and cancer
- Practical aspects of large register studies: Multiple states and multiple timescales: The diabetes and cancer study.
- Pre-and post-diagnosis diabetes as a risk factor for all-cause and cancer-specific mortality in breast, prostate, and colorectal cancer survivors: A prospective …
- Pre-diabetes and breast cancer outcomes: Abrogating the confounding effect of anti-diabetic therapy.
- Pre-existing diabetes and breast cancer prognosis among elderly women
- Pre-existing diabetes and lung cancer prognosis
- Pre-existing diabetes in early stage breast cancer patients is associated with lack of improvement in quality of life 2 years after diagnosis
- Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia
- Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis
- Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai
- Pre-existing type 2 diabetes and survival among patients with colorectal cancer
- Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II diabetes Mellitus and Colorectal cancer
- Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort.
- Prediabetes and type 2 diabetes mellitus and risk of thyroid cancer
- Prediabetes, diabetes, and risk of breast cancer: a case-control study
- Prediagnostic diabetes, body mass index, and survival of endometrial cancer: A prospective study.
- Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
- Predictive factors for differentiating pancreatic cancer-associated diabetes mellitus from common type 2 diabetes mellitus for the early detection of pancreatic cancer
- Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
- Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus
- Predictors of the Onset of Type 1 diabetes Obtained from Real-World Data Analysis in cancer Patients Treated with Immune Checkpoint Inhibitors
- Preexisting diabetes and risks of morbidity and mortality after gastrectomy for gastric cancer: a nationwide database study
- Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer
- Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes
- Prevalence and clinical profile of pancreatic cancer–associated diabetes mellitus
- Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes
- Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut
- Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes
- Prevalence of diabetes in a cancer population in a Malaga hospital
- Prevalence of diabetes in Japanese patients with cancer
- Prevalence of diabetes in patients admitted to a cancer hospital
- Prevalence of diabetes Mellitus and Metabolic Syndrome in Prostate cancer Patients given Androgen Deprivation Therapy
- Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers
- Prevalence of diabetes mellitus in pancreatic cancer patients
- Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer
- Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among US adults with diagnosed diabetes: findings from the …
- Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study
- Prevalence, awareness, control, and treatment of hypertension and diabetes in korean cancer survivors: a cross-sectional analysis of the fourth and fifth Korea …
- PREVALENCE, METABOLIC CONTROL, AND SURVIVAL IN AN ACADEMIC ONCOLOGY PRACTICE: cancer WITH diabetes
- Preventable diabetic complications after a cancer diagnosis in patients with diabetes: a population-based cohort study
- Preventing cancer, cardiovascular disease, and diabetes
- Preventing cancer, Cardiovascular Disease, and diabetes: A Common Agenda
- Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American cancer Society, the American diabetes Association, and the American …
- Prevention and treatment effects of edible berries for three deadly diseases: Cardiovascular disease, cancer and diabetes
- Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic
- Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone
- Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis
- Primary care cancer and diabetes complications screening of black women with type 2 diabetes
- Primary study of the relationship between diabetes and pancreatic cancer
- Primate-specific long non-coding RNA (LncRNA) genes as regulators and drug target candidates in human cancer and diabetes
- Probability of pancreatic cancer following diabetes: a population-based study
- Prognosis of colorectal cancer patients with diabetes according to medication adherence: A population-based cohort study
- Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
- Prognosis of Patients with Colorectal cancer with diabetes According to Medication Adherence: A Population-Based Cohort Study
- Prognosis of small cell lung cancer patients with diabetes treated with metformin
- Prognostic factors for resected non‐small cell lung cancer in patients with type 2 diabetes mellitus
- Prognostic Impact of diabetes Mellitus on Colorectal cancer
- Prognostic Impact of diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic cancer
- Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
- Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
- Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
- Prognostic Significance of Obesity and diabetes Mellitus in Women With Brain Metastases From Breast cancer Should Be Revisited
- Prognostic significance of type 2 diabetes in patients treated with surgery and irradiation for gingival cancer
- Prognostic value of metformin for non-small cell lung cancer patients with diabetes
- Program/Abstract# 48 A fly approach to cancer and diabetes
- Progress in the relationship between diabetes and prognosis of colorectal cancer
- Progress in the study on the correlation between Type 2 diabetes mellitus and colorectal cancer
- Progress of relationship between diabetes and papillary thyroid cancer
- Prohibitin–At the crossroads of obesity-linked diabetes and cancer
- Prolonged survival in lung cancer patients with diabetes mellitus
- Prolonged survival in patients with lung cancer with diabetes mellitus
- Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes
- Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study
- Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women
- Prospective study of a diabetes risk reduction diet and the risk of breast cancer
- Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
- Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka diabetes Registry
- Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
- Prospective study of diabetes mellitus and liver cancer in Japan
- Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
- Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men
- Prostate cancer patients with unmanaged diabetes or on insulin have worse outcomes and toxicities after treatment with radiation therapy
- Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
- Prostate cancer risk among men with diabetes mellitus (Spain)
- Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review
- Prostate cancer, diabetes Link Points to Potential Treatment with Metformin
- Prostate cancer: diabetes and prostate cancer—an open debate
- Prostate cancer: Hormone Therapy Associated with diabetes, Cardiovascular Disease
- Protective effect of diabetes against metastasis in patients with non–small cell lung cancer
- Protein-bound glycosaminoglycans in serum of patients with lung cancer and patients with diabetes mellitus
- Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes
- Proteomic analysis of pancreatic cancer associated with diabetes mellitus
- Proteomics Analysis of Gastric cancer Patients with diabetes Mellitus
- Psychological distress, resilience, social support and help-seeking behaviors in patients with type ii diabetes, breast cancer and hypertension
- PTEN link between cancer and diabetes
- PUK4 COMPARISON OF POSTTRANSPLANT NEW-ONSET diabetes AND cancer BETWEEN PERITONEAL AND HEMODIALYSIS RECIPIENTS …
- PWE-159 diabetes and Pancreatic cancer–Cause or Association?
- pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer
- Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer
- Quality and outcomes of diabetes care in patients diagnosed with cancer
- Quality of diabetes care among cancer survivors with diabetes
- Quality of diabetes care in breast, colorectal, and prostate cancer
- Quality of diabetes care in cancer: a systematic review
- Quantitative aspects of mitochondrial genome in cancer and diabetes
- Racial disparities and colorectal cancer survival in older adults with and without diabetes mellitus
- Racial disparities in breast cancer mortality among women with diabetes mellitus.
- Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status
- Racial Variation in the Relationship of diabetes with Pancreatic cancer Risk
- Racial/ethnic disparities in the risk of posttraumatic stress disorder symptoms among mothers of children diagnosed with cancer and Type-1 diabetes mellitus.
- Racial/Ethnicity Disparities In The Association Between diabetes And Pancreatic cancer In The Elderly Medicare Population
- Radiation Dose and Volume to the Pancreas and Subsequent Risk of diabetes Mellitus: A Report from the Childhood cancer Survivor Study
- Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood cancer Survivor study.
- Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
- Radical gastrectomy combined with modified gastric bypass surgery for gastric cancer patients with type 2 diabetes
- Raised glucose concentrations and diabetes are associated with cancer risk
- Rapid biochemical profiling of endothelial dysfunction in diabetes, hypertension and cancer metastasis by hierarchical cluster analysis of Raman spectra
- Rapid progression of breast cancer cell proliferation in diabetes: Role of polyamines
- Rare case of manifestation of erectile dysfunction soon after thyroidectomy because of thyroid cancer in 56-year-old man with diabetes mellitus type 2 and diabetic …
- Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model
- Re: Androgen-Deprivation Therapy and diabetes Control among Diabetic Men with Prostate cancer
- Re: Excess Risk of Primary Liver cancer in Patients With diabetes Mellitus
- Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
- Re: prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women
- Real life cancer comorbidity in Greek patients with diabetes mellitus followed up at a single diabetes center: an unappreciated new diabetes complication
- Rebuild: Recover from Heart Disease, cancer, diabetes and Other Serious Illness and be Healthier Than Ever Before
- Recent Advances in Histone Glycation: Emerging role in diabetes and cancer
- Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer
- Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15 …
- Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
- Recent data on Mediterranean diet, cardiovascular disease, cancer, diabetes and life expectancy.
- Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients
- Redefining the role of obesity, race and diabetes in Type I and Type II endometrial cancers: Potential targets for treatment beyond cancer itself
- Redox alterations in inflammatory diseases: diabetes, kidney failure and cancer
- Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis
- Reduced risk of prostate cancer among patients with diabetes mellitus
- Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients
- Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
- Reduced risk of prostate cancer in a cohort of Lithuanian diabetes patients
- Reducing cancer and cancer disparities: lessons from a youth-generated diabetes prevention campaign
- Reducing the gap by focusing the ethnicity and migration lenses: examples in cancer, heart disease and diabetes
- Reference frameworks for the health management of measles, breast cancer and diabetes (type II).
- Regarding measures of impact: diabetes and urothelial cancer
- Regional variations in cancer screening rates found in women with diabetes
- Registry-based analysis of cancer and diabetes combination: prevalence and features
- Related Factors and Risk Prediction of Type 2 diabetes Complicated with Liver cancer
- RELATION BETWEEN COMPLICATIONS OF TYPE II diabetes MELLITUS AND ANEMIA CAUSED BY CHEMOTHERAPY IN WOMEN WITH BREAST cancer
- Relation between dietary calcium and vitamin D and risk of diabetes and cancer: a review and perspective
- Relation of prediabetes and type 2 diabetes mellitus to thyroid cancer
- Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer
- Relationship between diabetes and pancreatic cancer
- Relationship between diabetes and risk of second primary contralateral breast cancer
- Relationship between diabetes Mellitus and Clinicopathological Stages of Breast cancer at Diagnosis
- Relationship between diabetes Mellitus and Colorectal cancer as well as its Metastasis
- Relationship between diabetes Mellitus and Lymphatic Metastasis in Patients with Colorectal cancer
- Relationship between diabetes Mellitus and Risk of Colorectal cancer: A META-ANALYSIS
- Relationship between diabetes mellitus and the site of colorectal cancer
- Relationship between gestational diabetes and endometrial cancer
- Relationship between HbA1c and cancer in people with or without diabetes: a systematic review
- RELATIONSHIP BETWEEN HISTORY OF GESTATIONAL diabetes AND THE RISK OF BREAST cancer: A POPULATION BASED COHORT STUDY
- Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis
- Relationship between obesity, diabetes and the risk of thyroid cancer
- Relationship between Obesity, diabetes, and the Risk of Thyroid cancer
- Relationship between pancreatic cancer and diabetes mellitus
- Relationship between pancreatic cancer‐associated diabetes and cachexia
- Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
- Relationship between type 2 diabetes and pancreatic cancer
- Relationship between type 2 diabetes mellitus and risk of breast cancer: a case-control study
- Relationship of diabetes and obesity with cancer incidence; review article
- Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis
- Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity
- Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
- Relationships of obesity and diabetes mellitus to other primary cancers in surgically treated gastric cancer patients
- Remedial applications of exosomes in cancer, infections and diabetes
- Renal Impairment Increases Serum cancer Antigen 125 Levels in Patients with Type 2 diabetes Mellitus
- Renin angiotensin system inhibitors may attenuate low LDL cholesterol‐related cancer risk in type 2 diabetes
- Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer”
- Reply to the letter by Fujishiro et al. concerning “Controversy regarding gastric cancer and diabetes”
- Report Clarifies Scientists’ Understanding of Association Between diabetes and cancer
- Report of the J apan diabetes Society/J apanese cancer Association joint committee on diabetes and cancer
- Report of the Japan diabetes Society (JDS)/Japanese cancer Association (JCA) joint committee on diabetes and cancer, second report
- Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
- Report of the JDS/JCA joint committee on diabetes and cancer
- Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition
- Research advances on diabetes-associated pancreatic cancer
- Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus
- Research Progress in New-onset diabetes and Early Diagnosis of Pancreatic cancer
- Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II diabetes and cancer
- Research Progress of Correlation between Type 2 diabetes Mellitus And Digestive System cancer Based on Meta-analysis
- Research Progress of Relationship between diabetes and Colorectal cancer [J]
- Research progress on the association of diabetes with pancreatic cancer
- Resectability of pancreatic cancer and diabetes
- Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to …
- Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study
- Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124 …
- Response to Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35 …
- Response to Letter to the Editor:” Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes-The Adiponectin Paradox”
- Response to Yang and Chan. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
- RESPONSE: Re: diabetes Mellitus and Risk of Colorectal cancer in the Singapore Chinese Health Study
- Response: The Association between Type 2 diabetes Mellitus and Colorectal cancer.
- Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
- Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
- Results of a community survey to assess African American and Latino knowledge, perceptions, and life style practices related to diabetes and cancer
- Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients
- Resveratrol’s potential in the adjunctive management of cardiovascular disease, obesity, diabetes, Alzheimer disease, and cancer
- Retinol binding protein 4: role in diabetes and cancer
- Retinol binding protein 4: role in diabetes and cancer
- Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
- Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
- Retraction Notice to: The cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of diabetes
- Retrospective analysis of the relation between diabetes mellitus and endometrial cancer
- Retrospective analysis of the relationship between type 2 diabetes mellitus and colorectal cancer
- Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
- Retrospective evaluation of Middle Eastern patients (pts) with type II diabetes mellitus (DM) and colorectal cancer (CRC): Validation of metformin effect on overall …
- Retrospective evaluation of patients with colorectal cancer (CRC) and type II non-insulin-dependent diabetes (NIDDM).
- Reversal of enhanced pancreatic cancer growth in diabetes by insulin
- Review of Associations Between Type 2 diabetes and cancer
- Risk analysis on diabetes mellitus patients complicating colorectal cancer
- Risk differences between prediabetes and diabetes according to breast cancer molecular subtypes
- Risk established between type II diabetes mellitus and cancer: a review
- Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a …
- Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age
- Risk factors for cancer development in type 2 diabetes: a retrospective case-control study
- Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus
- Risk factors for papillary thyroid cancer in obesity and diabetes mellitus
- Risk factors for radiation esophagitis and pneumonitis in esophageal cancer patients with diabetes or hypertension
- Risk factors of catheter-related bloodstream infections in cancer patients with diabetes
- Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes
- Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study
- Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
- Risk of bladder cancer in patients with diabetes: a retrospective cohort study
- Risk of bladder cancer in patients with diabetes: a retrospective cohort study.
- Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women
- Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study
- Risk of Breast cancer in Patients diagnosed with Type 2 diabetes (T2DM)
- Risk of cancer following hospitalization for type 2 diabetes
- Risk of cancer in a large cohort of US veterans with diabetes
- Risk of cancer in diabetes: the effect of metformin
- Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
- Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia
- Risk of cause‐specific death in individuals with cancer—modifying role diabetes, statins and metformin
- Risk of colon cancer recurrence in relation to diabetes
- Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study
- Risk of diabetes after para-aortic radiation for testicular cancer
- Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer
- Risk of diabetes Associated With cancer Development
- Risk of diabetes Associated With cancer Development—In Reply
- Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer
- Risk of diabetes, cancer, large vessel disease and mortality in young women with Polycystic Ovary Syndrome: a retrospective database analysis
- Risk of endometrial and breast cancer in patients with diabetes mellitus
- Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies
- Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan
- Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan
- Risk of Myocardial Infarction or diabetes During Androgen Deprivation Therapy for Prostate cancer: Does Comorbidity Influence Risk?
- Risk of prostate cancer across different racial/ethnic groups in men with diabetes: A retrospective cohort study
- Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan
- Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: a retrospective population-based time-dependent cohort study
- Risks of breast and endometrial cancer in women with diabetes: a population-based cohort study
- Risks of Colorectal cancers Associated with diabetes Were Particularly Increased in Middle-aged Men Running title: Colorectal cancer in Diabetic Patients
- Role for diabetes in colorectal cancer risk
- Role of breast cancer inhibitors on diabetes mellitus–an in silico approach
- Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
- Role of Heat Shock Protein 90 in diabetes and Pancreatic cancer Management
- Role of Mitochondria in Pancreatic Metabolism, diabetes, and cancer
- Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
- Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011
- Role of signal dynamics in the link between type 2 diabetes and cancer
- Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer
- Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus
- Rosemary leaf extract inhibits glycation, breast cancer proliferation, and diabetes risks
- Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
- Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
- Rosiglitazone use and the risk of bladder cancer in patients with type 2 diabetes
- SAT-134 Association between Serum Branched-Chain Amino Acids and cancer Risk: The Hong Kong diabetes Register (HKDR)
- Screening for Pancreatic cancer in Individuals With New-onset diabetes Mellitus
- Screening Strategy of Pancreatic cancer in Patients with diabetes Mellitus
- Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort …
- Secondhand Smoke Exposure, diabetes, Elevated Glucose Level Are Risk Factors for Uterine Cervical cancer: A Cross-Sectional Study From the Korea …
- Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006
- Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta …
- Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after
- Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study
- Self-rated health and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition-InterAct study: a case-cohort study
- Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in …
- Self-reported memory problems in adult-onset cancer survivors in the United States with or without: Type 2 diabetes mellitus, hypertension and hyperlipidemia.
- Senile Colon cancer with diabetes Patients Perioperative Features and Nursing Intervention [J]
- Sera anti-p53 antibody provides new information which explains the link between diabetes and cancer
- Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective
- Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø …
- Serum HSP70 level in patients with endometrial cancer with and without diabetes
- Serum Levels of 8-Hydroxy-2′-Deoxyguanosine DNA in Patients with Breast cancer and Endometrial cancer with and without diabetes Mellitus
- Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
- Serum proteomic analysis of pancreatic cancer associated diabetes
- Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes
- Session 4: CVD, diabetes and cancer A dietary portfolio for management and prevention of heart disease: Symposium on ‘Dietary management of disease’
- Session 4: CVD, diabetes and cancer Diet, insulin resistance and diabetes: the right (pro) portions: Symposium on ‘Dietary management of disease’
- Session 4: CVD, diabetes and cancer Evidence for the use of the Mediterranean diet in patients with CHD: Symposium on ‘Dietary management of disease’
- SESSION IA| HEALTHCARE DISPARITIES: TYPE 2 diabetes & BREAST cancer
- Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry
- Severe Visceral Obesity, Fatty Liver and diabetes after Orchiectomy for Prostate cancer
- Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
- Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and …
- Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic …
- Sex-and site-specific differences in colorectal cancer risk among people with type 2 diabetes
- Sex-specific association between family history of diabetes and risk of colorectal cancer: two prospective cohort studies
- SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
- Shaping environments for reductions in type 2 diabetes risk behaviors: A look at CVD and cancer interventions
- Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study
- Should healthcare be guaranteed for cancer but not diabetes?
- Significance of angiotensin targeting on treatment of liver metastasis in colorectal cancer patients with diabetes
- Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
- Significantly increased risk of cancer in diabetes mellitus patients: a meta‐analysis of epidemiological evidence in Asians and non‐Asians
- Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
- Sitagliptin and oral cancer risk in type 2 diabetes patients
- Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
- Sitagliptin may reduce breast cancer risk in women with type 2 diabetes
- Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
- Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
- Sitagliptin use may reduce oral cancer risk in patients with type 2 diabetes
- Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study
- Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
- Site-specific cancer risk in people with type 2 diabetes: Nationwide population-based cohort study in Korea
- Skeletal muscle microRNAs in human cancer cachexia and Type 2 diabetes
- Sleep apnea: a common mechanism for the deadly triad—cardiovascular disease, diabetes, and cancer?
- Small cell lung cancer expressing glutamate decarboxylase with latent autoimmune diabetes in adults
- Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
- Small-cell lung cancer presenting as diabetes insipidus and cushing’s syndrome
- Smoking Despite Lung cancer or diabetes: A Pressing Challenge to Smoking Abstinence
- Smoking, alcohol, diabetes, obesity, socioeconomic status, and the risk of colorectal cancer in a population-based case–control study
- Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients
- Social Welfare Approaches for Patients with Concurrent diabetes and cancer.
- Socioeconomic characteristics, life style, diabetes, family history of cancer and risk of pancreatic cancer
- Sodium–glucose cotransporter 2 inhibitors and the short-term risk of breast cancer among women with type 2 diabetes
- SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes
- Speaking with one voice on worksite wellness: the American cancer Society, the American diabetes Association, and the American Heart Association
- Spontaneous remission of cranial diabetes insipidus due to concomitant development of ADH-producing lung cancer–an autopsied case
- Sporadic Pancreatic cancer: Glucose Homeostasis and Pancreatogenic Type 3 diabetes
- Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus
- Standard risk factors for lung cancer, cardiac infarct, apoplexy, diabetes mellitus and their changes in psychosocial context
- Statin use and cancer incidence in patients with type 2 diabetes mellitus: a network meta-analysis
- Statin Use and the Risk of Colorectal cancer in Patients with diabetes: 881
- Statins and finasteride use differentially modify the impact of metformin on prostate cancer incidence in men with type 2 diabetes
- Statins and the risk of gastric cancer in diabetes patients
- Statistical analysis of the effect of metformin use on endometrial cancer incidence in patients with type 2 diabetes
- Stem cell-based approach in diabetes and pancreatic cancer management
- Steroid-induced diabetes in cancer patients
- Storage of vitamin D in adipose tissue and associations between vitamin D related genetic variants and diabetes, myocardial infarction, cancer, death, and low bone …
- Stratification of cancer and diabetes based on circulating levels of formate and glucose
- Stratification of cancer and diabetes based on circulating levels of formate and glucose
- Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
- Stroke, lung cancer, and diabetes health beliefs and lifestyle practices of Vietnamese elders: Implications for geriatric rehabilitation
- Structural and Biophysical Characterization of SPOP-Client Interactions Involved in diabetes and cancer
- Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
- Studies on the relationships between blood trace metal concentrations and the clinical status of patients with cerebrovascular disease, gastric cancer and diabetes …
- Study of correlation between pancreatic cancer and diabetes mellitus [J]
- Study of serum IGF-1, IGFBP-3 and insulin levels in patients with type 2 diabetes mellitus and their relationship with colorectal cancer
- Study of the Association Between Antihyperglycemic Therapy and cancer in Patients with Type 2 diabetes Mellitus
- Study of the Prevalence of Chronic Diseases (cancer, diabetes, Heart Disease) and Its Relationship with the Elderly’s Quality Of Life
- Study on the association between the different levels of C-peptide of type 2 diabetes and colorectal cancer risk
- Study on the effect of metformin in patients of metastatic renal cell cancer with diabetes receiving tyrosine kinase inhibitor therapy
- Study On The Prevalence Of Various Forms Of cancer In Diabetic Patients Hospitalized In The National Institute Of diabetes, Nutrition And Metabolic …
- STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
- STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
- Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and …
- Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
- Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan
- Substitutions between dairy product subgroups and risk of type 2 diabetes: the Danish Diet, cancer and Health cohort
- Successful use of endoscopic argon plasma coagulation for patients with early gastric cancer and diabetes mellitus
- SUN-675 Breast cancer Treatment Causes diabetes
- SUN-688 Pancreatic cancer in Longstanding diabetes
- Superior Mesenteric Artery Syndrome Preceded by diabetes Insipidus in Advanced Lung cancer with Pituitary Metastasis–A Case Report
- Superoxide dismutases: significances in aging, diabetes, ischemia and cancer
- Supplemental Material The Association of Arsenic Metabolism with cancer, Cardiovascular Disease and diabetes: A Systematic Review of the Epidemiological …
- Surgical treatment of gastric cancer in elderly patients combinded with diabetes
- Surgical Treatment of Large Bowel cancer with diabetes Mellitus
- Survival advantage associated with metformin usage in patients with colorectal cancer (CRC) and type II noninsulin-dependent diabetes (NIDDM).
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
- Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus
- Survival and glycemic control in patients with colorectal cancer and diabetes mellitus
- Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus
- Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
- Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis
- Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer
- Survival of colorectal cancer patients with diabetes mellitus: A meta-analysis
- Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
- Survival of non-small cell lung cancer (NSCLC) patients with and without diabetes mellitus (DM): Findings from the cancer Care Outcomes Research and Surveillance …
- Survival of patients with cervical cancer and diabetes: An exploratory study.
- Survival of patients with lung cancer and diabetes mellitus
- Survival of patients with stage IV lung cancer with diabetes treated with metformin
- Survival of resectable pancreatic cancer patients with diabetes
- Suva Residents’ Views on cancer, diabetes and HIV in The Fiji Times
- Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage
- SYMPOSIUMS: diabetes AND cancer: CAN RESVERATROL BE A GOOD CANDIDATE IN THIS TSUNAMI?
- Syndecan as a messenger to link diabetes and cancer
- Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong diabetes Registry
- Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
- Synthesis of Tin Oxide Nanofibers for Lung cancer, diabetes and Kidney Malfunction Detection
- Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
- Systematic review and meta‐analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
- Systematic Survey of the Role of IGF in the Link Between diabetes and cancer
- Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic‐induced diabetes insipidus
- Targeting acidity in cancer and diabetes
- Targeting dipeptidyl peptidase-4 (DPP-4) and fibroblast activation protein (FAP) for diabetes and cancer therapy
- Targeting receptors of advanced glycation end products (RAGE): preventing diabetes induced cancer and diabetic complications
- Targeting unfolded protein response in cancer and diabetes
- Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study
- TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer
- Technology-Enhanced consultations in diabetes, cancer, and heart failure: protocol for the qualitative analysis of remote consultations (QuARC) project
- Television watching and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam Study
- Test–retest reliability of self-reported diabetes diagnosis in the Norwegian Women and cancer Study: a population-based longitudinal study (n= 33,919)
- Testing Mice at Risk of Pancreatic cancer for Altered Protein Pathways Found in diabetes
- Texas Health Insurance Coverage for Prevention and Screening of cancer, Cardiovascular Disease, and diabetes
- TGFBIp mediated apoptosis: A role in cancer and diabetes mellitus type II
- TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
- The activation of ERK1/2 and JNK MAPK signaling by insulin/IGF-1 is responsible for the development of colon cancer with type 2 diabetes mellitus
- The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its …
- The American diabetes Association, the American cancer Society, and the American Heart Association
- The American diabetes Association, the American cancer Society, and the American Heart Association: A triumvirate of hope for the nation’s health
- The application of refined nursing in postoperative patients with breast cancer and diabetes
- The assessment of molecular markers of cell interaction and lipid peroxidation in rats with alloxan diabetes and trans-planted liver cancer after intravenous injection of …
- The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6-months post-chemotherapy
- The association between diabetes and breast cancer stage at diagnosis: a population-based study
- The association between diabetes and cancer incidence and mortality in the NIH-AARP study
- The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China
- The Association between diabetes Mellitus and Colorectal cancer Stage at Presentation: Presidential Poster: 1559
- The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer
- The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans
- The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis
- The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes
- The association between gestational diabetes mellitus and cancer in women: a systematic review and meta-analysis of observational studies
- The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
- The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
- The association between paternal prostate cancer and type 2 diabetes
- The Association between Patient Characteristics and Use of Statin and Metformin among Elderly Women with Breast cancer and diabetes
- The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study
- The Association between thyroid cancer and type 2 diabetes mellitus
- The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women
- The Association between Type 2 diabetes Mellitus and Colorectal cancer.
- The Association between Type 2 diabetes Mellitus and Colorectal cancer.
- The association between type 2 diabetes mellitus and thyroid cancer
- The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms
- The association of arsenic metabolism patterns with cancer, cardiovascular disease and diabetes: A systematic review of the epidemiological evidence
- The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: a systematic review of the epidemiological evidence
- The Association of Arsenic Metabolism with cancer, Cardiovascular Disease, and diabetes: A Systematic Review of the Epidemiological Evidence
- The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study
- The association of diabetes and obesity with prostate cancer progression: HCaP‐NC
- The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series
- The Association of diabetes Mellitus with Colorectal cancer and Polyps in Asymptomatic Patients Undergoing Screening Colonoscopy: 447
- The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
- The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
- The association of diabetes with breast cancer incidence and mortality in the Long Island Breast cancer Study Project
- The association of diabetes with colorectal cancer risk: the Multiethnic Cohort
- The association of diabetes with risk of prostate cancer defined by clinical and molecular features
- The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
- The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: a systematic review with meta …
- The association of hyperinsulinemia with cardiovascular risk and cancer poses new challenges in the treatment of the insulin resistance type 2 diabetes patient
- The association of recently-diagnosed diabetes and long-term diabetes with survival in pancreatic cancer patients: a pooled analysis
- The Baltimore Alliance for the Prevention and Control of Hypertension and diabetes: a model for developing a colorectal cancer community outreach program.
- The bidirectional interation between pancreatic cancer and diabetes
- The Biology of the Deadly Love Connection Between Obesity, diabetes, and Breast cancer
- The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
- The clinical dependabilities between type 2 diabetes and lung cancer.
- The clinical effect of metformin on the survival of lung cancer patients with diabetes: a comprehensive systematic review and meta-analysis of retrospective …
- The Clinical Features of Patients with Type 2 diabetes and Colorectal cancer
- The Clinical Observation of diabetes Mellitus Following Cisplatin-based Chemotherapy on Head and Neck cancer [J]
- The Combined Impact of Chronic Kidney Disease and diabetes on the Risk of Colorectal cancer Depends on Sex: A Nationwide Population-Based Study
- The complex dual diagnosis of diabetes and cancer.
- The complex role of branched chain amino acids in diabetes and cancer
- The complexities of obesity and diabetes with the development and progression of pancreatic cancer
- The correlation analysis of primary liver cancer with Type 2 diabetes
- The Correlation Between Dairy Product Consumption and Gastrointestinal Bleed, Ovarian cancer, and diabetes in Infants: A Meta‐Analysis Approach
- The correlation between diabetes and pancreatic cancer and the imaging findings
- The correlation between type-2 diabetes and lung cancer
- The decline in cancer incidence in patients with long-duration type 1 diabetes: what really happens over time?
- The design, synthesis and evaluation of new chemical entities for the development of drugs against cancer, diabetes, autoimmune disorders and infectious …
- The development of fulminant type 1 diabetes during chemotherapy for rectal cancer
- The diabetes Drug Canagliflozin Enhances the Response of Prostate cancer to Radiotherapy
- The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration
- The diabetes–cancer link
- The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel
- The double trouble of metabolic diseases: the diabetes–cancer link
- The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and cancer
- The duration of obesity and the risk of type-2 diabetes, cardiovascular disease, cancer and mortality
- The dysfunction of NK cells in patients with type 2 diabetes and colon cancer
- The early diagnosis of pancreatic cancer and diabetes: what’s the relationship?
- The Effect of Aging Lung cancer Combined with Type Ⅱ diabetes Mellitus by Shenmai Injection
- The effect of Benign Thyroid Disease, diabetes Mellitus and Physical Activity on Breast cancer Risk
- The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
- The effect of diabetes mellitus on lung cancer prognosis: a PRISMA-compliant meta-analysis of cohort studies
- The effect of diabetes mellitus on prognosis of patients with non-small-Cell lung cancer: a systematic review and meta-analysis
- The effect of diabetes on the perioperative outcomes of colorectal cancer surgery patients
- The effect of diabetes on the risk of endometrial cancer: an updated a systematic review and meta-analysis
- The effect of diabetes with pharmacotherapy for breast cancer on care resource use
- The effect of exposure to thiazolidinediones on the development of head-and-neck cancer in patients with diabetes mellitus
- The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control
- The Effect of intensive Glycemic Control on Postoperative Gastric cancer Patients Combined with diabetes
- The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index< 35 kg/m2: preliminary results
- The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
- The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis
- The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
- The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
- The effect of metformin on mortality following cancer among patients with diabetes
- The effect of metformin on oncological outcomes in patients with cervical cancer with type 2 diabetes mellitus
- The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus
- The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes
- The effect of metformin on the clinicopathological features of breast cancer with type 2 diabetes
- The effect of metformin on the progression of non-small cell lung cancer with diabetes mellitus: A review of studies between 2015 and 2017
- The effect of metformin use and the incidence of prostate cancer in type 2 diabetes mellitus patients: A nationwide population-based study
- The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus
- The Effect of Obesity and diabetes on Intermediate to High Grade Prostate cancer Patients Treated with Radical Prostatectomy
- The effect of obesity on the formation of cancer risk in patients with type 2 diabetes mellitus (literature review)
- The Effect of Pre-existing diabetes on the Incidence of Postradiation Retinopathy in Head and Neck cancer Patients
- The Effect of Prostate cancer Diagnosis on Adherence to Medications for Patients with Type 2 diabetes
- The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
- The effect of type 2 diabetes on selected clinical parameters and disease outcome in patients with colorectal cancer
- The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- The Elusive Link Between cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in diabetes
- The Emerging Link between Metformin Therapy for Type 2 diabetes Mellitus and Colorectal cancer
- The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus
- The epidemiologic relationship between diabetes and cancer
- The epidemiologicalcharacteristics of 1205 cancer patients with previous type 2 diabetes mellitus
- The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer
- The epidemiology of diabetes and cancer
- The Estimation of Thyroid cancer Risk based on Type 2 diabetes Mellitus and ABO Blood Group.
- The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders
- The evaluation of Entamoeba gingivalis occurrence in samples from patients with cancer and diabetes
- The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes—the 2001–2006 ENTRED cohort
- The experience of developing new-onset diabetes after cancer treatments in middle age and older adults
- The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus
- The expression of Transgelin in pancreatic cancer accompanied with diabetes and its effects on the migration and invasion of SW1990 cell line
- The frequency of cancer in diabetes mellitus
- THE GENETICAL ASSOCIATION BETWEEN PROSTATE cancer AND TYPE 2 diabetes
- The global implications of diabetes and cancer.
- The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer
- The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention
- The impact of cancer on diabetes outcomes
- The Impact of Comorbid diabetes on Short-Term Postoperative Outcomes in Stage I/II Colon cancer Patients Undergoing Open Colectomy
- The Impact of Comorbid diabetes Type 2 on Quality of Life in cancer Patients Undergoing Chemotherapy.
- The impact of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
- The impact of diabetes and obesity on endometrial cancer outcomes.
- The impact of diabetes and other metabolic disorders on prostate cancer prognosis
- The impact of diabetes in head and neck cancer
- The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
- The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy
- The impact of diabetes mellitus and obesity on pathologic complete response rate of neoadjuvant chemoradation for gastroesophageal cancer: A retrospective review.
- The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study
- The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis
- The impact of diabetes mellitus on early cervical cancer in Αsia: A population-based cohort study.
- The impact of diabetes mellitus on prognosis of early breast cancer in Asia
- The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
- The Impact of diabetes Mellitus on Survival in Men with Clinically Localized Prostate cancer Treated with Permanent Interstitial Brachytherapy
- The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy
- The Impact of diabetes Mellitus on the Second Primary Malignancies in Colorectal cancer Patients
- The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer
- The impact of diabetes on breast cancer treatments and outcomes: a population-based study
- The Impact of diabetes on Breast cancer Treatments and Outcomes: A Population-Based Study
- The Impact of diabetes on Colorectal cancer Stage at Diagnosis: A Population-Based Cohort Study
- The impact of diabetes on gynecologic cancer: Current status and future directions
- The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry
- The impact of diabetes on survival following breast cancer
- The impact of diabetes on survival in women with ovarian cancer
- The impact of diabetes on the risk of prostate cancer development according to body mass index: a 10-year nationwide cohort study
- The Impact of diabetes on the Symptoms of Breast cancer Survivors
- The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
- The Impact of diabetes Treatment on Survival in a Breast cancer/diabetes Model
- The impact of gastrectomy on diabetes and related conditions, coronary heart disease, stroke, cancer, and survival: follow-up from the Honolulu heart program
- The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits …
- The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research
- The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
- The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
- The impact of physician communication on diabetes management in cancer survivors.
- The Impact of Race and diabetes on Mortality among Breast cancer Patients
- The Impact of Resolution of diabetes After Radical Pancreatic Resection on Long-term Survival of Patients With Pancreatic cancer
- The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis
- The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
- The impact of type 2 diabetes mellitus on cancer‐specific survival: a follow‐up study in Sweden
- The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in T aiwan
- The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
- The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer.
- The incidence of cardiovascular disease, cancer and type 2 diabetes comorbidities in HIV infection: A systematic review
- The increased risk of cancer in obesity and type 2 diabetes: potential mechanisms
- The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry
- The individual and combined effects of obesity and type 2 diabetes on cancer predisposition and survival
- The influence of alloxan diabetes on experimental cancer.
- The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
- The influence of diabetes mellitus and metformin on distant metastases in oropharyngeal cancer: a multicenter study
- The Influence of diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal cancer: A Multicenter Study
- The influence of diabetes severity on guideline-concordant treatment for stage I-III breast cancer in the National Program of cancer Registries (NPCR) patterns of care …
- The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- The influence of psychological stress on the initiation and progression of diabetes and cancer
- The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese
